{"Title": ["Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals", "Is Intercept Pharmaceuticals Stock a Buy?", "3 Top Biotech Stocks to Buy in June", "5 Top Stocks to Buy in June", "Is Acadia Pharmaceuticals a Buy?", "Here's My Single Best Investment Idea for June", "Health Care Sector Update for 05/22/2020: AQST,XSPA,NAVB,XSPA,ICPT", "Intercept Pharmaceuticals Shares Fall 13% After FDA Delays an Advisory Committee Meeting", "Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals", "Health Care Sector Update for 05/22/2020: NAVB,XSPA,ICPT", "Why Intercept Pharmaceuticals Is Plunging Today", "BUZZ-U.S. STOCKS ON THE MOVE-Abbott, Tetraphase Pharma, HPE", "Stock Alert: Intercept Pharmaceuticals Down 14%", "Intercept: FDA Postpones Meeting On NDA For Liver Fibrosis Treatment; Stock Down", "Got $1,000? Here Are the Smartest ETFs to Buy and Hold for 5 Years", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "BUZZ-U.S. STOCKS ON THE MOVE-LiveRamp, T2 Biosystems, Foot locker", "BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Novavax, Cymabay Therapeutics", "BUZZ-U.S. STOCKS ON THE MOVE-Cymabay Therapeutics, California Resources, Novavax", "Intercept Pharmaceuticals Inc (ICPT) Q1 2020 Earnings Call Transcript", "Why Intercept Pharmaceuticals Stock Caught Fire in April", "June 26th Options Now Available For Intercept Pharmaceuticals (ICPT)", "BUZZ-U.S. STOCKS ON THE MOVE-GM, Axcella, Beyond Meat, SmileDirect", "3 Top Stocks That Will Make You Richer in May (and Beyond)", "BUZZ-U.S. STOCKS ON THE MOVE-Helius Medical, Datadog, Novavax", "Noteworthy Friday Option Activity: GOOG, MA, ICPT", "The 3 Best Small-Cap Stocks to Buy With Your Stimulus Check", "Will FDA Approve First NASH Drug In 2020?", "2 Dirt-Cheap Growth Stocks to Buy Now", "First Week of May 8th Options Trading For Intercept Pharmaceuticals (ICPT)", "Why Intercept Pharmaceuticals Stock Got Crushed in March", "30 Top Stocks and Funds to Beat the COVID-19 Bear Market", "Bullish Two Hundred Day Moving Average Cross - ICPT", "U.S. Now Has Most Virus Cases, BSGM To Develop COVID-19 Drug, FDA Nod For BMY", "3 Small-Cap Stocks to Buy Following the COVID-19 Crash", "Intercept Pharmaceuticals is Now Oversold (ICPT)", "Will COVID-19 Derail New Drugs?", "Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals", "Intercept Pharmaceuticals Inc (ICPT) Q4 2019 Earnings Call Transcript", "Is Intercept Pharmaceuticals Stock a Buy?", "How The Pieces Add Up: IYH Targets $234", "Noteworthy Monday Option Activity: CHNG, ERI, ICPT", "Is Viking Therapeutics' Stock a Buy?", "Notable Wednesday Option Activity: ICPT, NVRO, ONB", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "Intercept Pharmaceuticals Enters Oversold Territory (ICPT)", "Interesting ICPT Put And Call Options For September 18th", "Where Will Intercept Pharmaceuticals Be in 5 Years?", "NGM Biopharmaceuticals Reports a Successful NASH Trial", "2 Mid-Cap Biotech Stocks to Buy Right Now", "Notable Monday Option Activity: MLM, TEAM, ICPT", "3 Biotech Stocks to Bank on for Buyouts in 2020", "SPDR S&P Biotech ETF Experiences Big Outflow", "XBI, ICPT, SGEN, ALNY: Large Inflows Detected at ETF", "Analysts Expect 17% Gains Ahead For FBT", "Noteworthy Monday Option Activity: ARNA, MYGN, ICPT", "2 Small-Cap Biotech Stocks to Watch in 2020", "Here's Why Intercept Pharmaceuticals Stock Rose 48.9% in November", "Notable Monday Option Activity: V, ICPT, AYI", "January 2020 Options Now Available For Intercept Pharmaceuticals (ICPT)", "These 3 Biotech Stocks Could More Than Double in 2020, Says Wedbush", "CCXI Is Red Hot, ZGNX On Watch, FDA Snubs ADMP", "FBT, QGEN, SGEN, ICPT: Large Outflows Detected at ETF", "20 Stocks That Could Double Your Money in 2020", "Drugs That Missed Key Goals In Phase III Trials", "Up 19.2%, Is Viking Therapeutics Stock Still a Buy?", "Intercept Pharmaceuticals Inc (ICPT) Q3 2019 Earnings Call Transcript", "3 Things to Watch From the Pharmaceutical Industry's Liver Meeting", "Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals", "Notable Friday Option Activity: LVS, ICPT, MPC", "Will The Pace of M&A Pick Up Following The Biotech Sector\u2019s Pounding?", "Will Insiders Be Tempted To Buy More ICPT At The New 52-Week Low?", "Better Buy: Intercept Pharmaceuticals or Genfit?", "Monday 8/26 Insider Buying Report: ICPT, DFIN", "3 Small-Cap Stocks With Big-Cap Potential", "Add Up The Pieces: RXL Could Be Worth $113", "Intercept Pharmaceuticals Inc (ICPT) Q2 2019 Earnings Call Transcript", "What You'll Want to Know About Intercept Pharmaceuticals' Q2 Update", "3 Top Healthcare Stocks to Buy in July", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "Noteworthy Monday Option Activity: ICPT, LMT, RDNT", "Better Buy: Intercept Pharmaceuticals vs. CV Sciences", "7 Stocks to Buy for Monster Growth", "3 Top Biotech Stocks to Buy Right Now", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "2 Reasons Gilead Sciences' NASH Program Could Bounce Back", "5 Top Pharmaceutical Stocks to Buy in 2019", "Intercept Pharmaceuticals Enters Oversold Territory (ICPT)", "Noteworthy Thursday Option Activity: GM, GILD, ICPT", "Intercept Pharmaceuticals Becomes Oversold (ICPT)", "May 31st Options Now Available For Intercept Pharmaceuticals (ICPT)", "3 Top Healthcare Stocks to Buy in April", "SPDR S&P Biotech ETF Experiences Big Outflow", "3 Top Healthcare Stocks to Buy in April", "Gilead to Collaborate with Novo Nordisk for NASH Treatment", "Noteworthy Thursday Option Activity: GM, GILD, ICPT", "Noteworthy Thursday Option Activity: GM, GILD, ICPT", "Intercept Pharmaceuticals Becomes Oversold (ICPT)", "May 31st Options Now Available For Intercept Pharmaceuticals (ICPT)", "Health Care Sector Update for 04/11/2019: JNJ,ICPT,INNT,SGEN", "ICPT Makes Notable Cross Below Critical Moving Average", "Why Intercept's Success Was a Big Disappointment", "Why Intercept Pharmaceuticals, Weight Watchers International, and Canopy Growth Slumped Today", "Friday's ETF with Unusual Volume: FNY", "Health Care Sector Update for 04/11/2019: ICPT,INNT,SGEN", "Noteworthy Wednesday Option Activity: ICPT, MHK, PANW", "Noteworthy Wednesday Option Activity: ICPT, MHK, PANW", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences", "Novartis (NVS) to Acquire Subsidiary of IFM Therapeutics", "3 Top Biotech Stocks to Buy Right Now", "Health Care Sector Update for 04/11/2019: JNJ,ICPT,INNT,SGEN", "Health Care Sector Update for 04/11/2019: ICPT,INNT,SGEN", "Noteworthy Wednesday Option Activity: ICPT, MHK, PANW", "Noteworthy Wednesday Option Activity: ICPT, MHK, PANW", "Why Intercept Pharmaceuticals Stock Hit the Skids in February", "Intercept (ICPT) Up on Q4 Revenue Beat, NASH Study in Focus", "Notable Friday Option Activity: ICPT, C, CBS", "ICPT Makes Bullish Cross Above Critical Moving Average", "2 Biotechs With Big Dates in April", "Conatus (CNAT) Declines on Failure of NASH Fibrosis Study", "Interesting ICPT Put And Call Options For May 17th", "3 Top Mid-Cap Stocks to Buy Right Now", "Is Viking Therapeutics a Buy?", "3 Top U.S. Stocks to Watch in February", "Intercept Pharmaceuticals (ICPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release", "$35 Billion Market! Positive Clinical Trial! Yet Shares Are Down?", "Why Intercept Pharmaceuticals Stock Is Jumping Today", "Interesting ICPT Put Options For April 12th", "Intercept Pharmaceuticals (ICPT) Q4 2018 Earnings Conference Call Transcript", "3 Top Mid-Cap Stocks to Buy Right Now", "Is Viking Therapeutics a Buy?", "3 Top U.S. Stocks to Watch in February", "Intercept Pharmaceuticals (ICPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release", "The Zacks Analyst Blog Highlights: Intercept, Gilead, Vertex, Alkermes and Clovis", "Noteworthy Thursday Option Activity: IMDZ, TTEC, ICPT", "Intercept Pharmaceuticals Investors Strap In for a Wild Ride", "Biotech Stock Roundup: ICPT Strong on NASH Drug Data, Collaborations & More", "Intercept Pharmaceuticals (ICPT) Surges: Stock Moves 6.1% Higher", "Intercept Reports Positive Top-Line Data for NASH, Shares Up", "Here's Why Intercept Pharmaceuticals Changed Course Today", "Wednesday's ETF Movers: XME, XBI", "The Zacks Analyst Blog Highlights: Intercept, Gilead, Vertex, Alkermes and Clovis", "Mid-Morning Market Update: Markets Edge Higher; Walmart Tops Q4 Expectations", "Health Care Sector Update for 02/19/2019: ICPT, MDT, NEO, JNJ, PFE, ABT, MRK, AMGN", "Wall Street Tips Lower Ahead of Opening Bell as US-China Trade Talks Resume", "US Futures Slump as US-China Trade Talks Resume", "Intercept's drug for patients with liver fibrosis due to NASH meets main goal", "Why Intercept Pharmaceuticals, PG&E, and Superior Energy Services Jumped Today", "Consumer Sector Update for 02/19/2019: MOR,CNDT,ICPT,CLVS,ALKS", "Why Intercept Pharmaceuticals Stock Is Soaring Today", "Notable Tuesday Option Activity: SQ, ICPT, CTRL", "Intercept Pharma (ICPT) stock upgraded to Market Outperform", "The Biggest Biotech Binary Event in 2019 Is Just Around the Corner", "Analysts Anticipate IYH Will Reach $216", "Are Options Traders Betting on a Big Move in Intercept Pharmaceuticals (ICPT) Stock?", "Notable Tuesday Option Activity: BTU, TGT, ICPT", "Gilead (GILD) Collaborates With Yuhan for NASH Candidates", "Intercept Pharmaceuticals (ICPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release", "Notable Tuesday Option Activity: SQ, ICPT, CTRL", "Intercept Pharma (ICPT) stock upgraded to Market Outperform", "The Biggest Biotech Binary Event in 2019 Is Just Around the Corner", "Analysts Anticipate IYH Will Reach $216", "The 10 Best Stocks to Buy to Finish Out 2018", "Noteworthy Thursday Option Activity: BBY, ICPT, TOCA", "Monday's ETF Movers: FBT, OIH", "My Top Portfolio Holdings for 2019", "Intercept (ICPT) Benefits from Ocaliva's Recovery in 2018", "IYH's Underlying Holdings Imply 15% Gain Potential", "Why Viking Therapeutics Stock Is Bolting Higher Today", "Why Intercept Pharmaceuticals, Inc. Stock Broke Down in October", "December 28th Options Now Available For Intercept Pharmaceuticals (ICPT)", "Intercept (ICPT) Gains on Earnings and Revenue Beat in Q3", "Better Buy: Intercept Pharmaceuticals vs. Genfit", "Health Care Sector Update for 10/31/2018: ICPT,NUVA,EXAS,CLVS", "Better Buy: Intercept Pharmaceuticals Inc. vs. Madrigal Pharmaceuticals", "Where Will Gilead Sciences, Inc. Be in 5 Years?", "3 Top Mid-Cap Stocks to Buy Immediately", "Noteworthy Friday Option Activity: SAM, VFC, ICPT", "5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage", "FBT, TECH, IQV, ICPT: ETF Inflow Alert", "Intercept Pharmaceuticals (ICPT) Reports Q3 Loss, Tops Revenue Estimates", "Can This Tiny Biotech Revolutionize a $35 Billion Market?", "Why Intercept Pharmaceuticals, Inc. Stock Raced Higher in September", "3 Small Biotech Stocks at 52-Week Highs -- Are They Buys?", "Noteworthy Tuesday Option Activity: ICPT, CACC, DAL", "Health Care Sector Update for 10/02/2018: VSTM,MMSI,JNJ,ICPT", "First Week of November 16th Options Trading For Intercept Pharmaceuticals", "5 Biotech Stocks to Play the Sector\u2019s Next Big Trend: NASH", "Forget Gilead Sciences: Intercept Pharmaceuticals, Inc. Is a Better Growth Stock", "Notable Monday Option Activity: ICPT, TPX, X", "Is Viking Therapeutics the Best NASH Stock to Buy Now?", "Viking Therapeutics and Madrigal Pharmaceuticals Are Racing to the Finish Line in NASH", "XBI, ICPT, SRPT, REGN: Large Outflows Detected at ETF", "Insiders Were Right: ICPT Makes New 52-Week High", "3 Top Stocks for Investing in Pharma's Next $35 Billion Market", "Here's Why Intercept Pharmaceuticals Jumped 22.7% in August", "XBI, ICPT, SRPT, REGN: ETF Outflow Alert", "Noteworthy Wednesday Option Activity: ICPT, LULU, HDS", "Is Intercept Pharmaceuticals, Inc. a Buy?", "Health Care Sector Update for 08/15/2018: ICPT,CGC,WEED.TO,STZ,LLY,EARS", "IYH's Holdings Imply 10% Gain Potential", "XBI, ICPT, REGN, HRTX: Large Outflows Detected at ETF", "2 Growth Stocks That Could Make You Rich", "Why Intercept Pharmaceuticals Stock Is Moving Higher Today", "Notable ETF Outflow Detected - XBI, ICPT, SRPT, HRTX", "Noteworthy Friday Option Activity: CMPR, ELY, ICPT", "XBI, HRTX, ICPT, REGN: Large Inflows Detected at ETF", "Intercept (ICPT) Q2 Loss Narrower-Than-Expected", "What's in Store for Intercept (ICPT) This Earnings Season?", "Can AppFolio (APPF) Keep Earnings Streak Alive in Q2?", "What's in the Store for IPG Photonics (IPGP) in Q2 Earnings?", "What's in the Offing for Castlight (CSLT) in Q2 Earnings?", "Intercept (ICPT) Gains on Solid Q2 Results, Ocaliva Recovers", "Noteworthy Friday Option Activity: CMPR, ELY, ICPT", "XBI, HRTX, ICPT, REGN: Large Inflows Detected at ETF", "Intercept (ICPT) Q2 Loss Narrower-Than-Expected", "What's in Store for Intercept (ICPT) This Earnings Season?", "We Did The Math AMCA Can Go To $30", "Friday's ETF Movers: FBT, FM", "Viking Therapeutics, Buy the Dip?", "Celgene (CELG) Q2 Earnings: Disappointment in Store?", "Will HIV Sales Drive Gilead (GILD) to Beat in Q2 Earnings?", "NASH Space in Focus as Galmed (GLMD) Posts Positive Data", "Galmed (GLMD) Soars on Positive NASH Data on Aramchol", "Interesting ICPT Put And Call Options For June 2019", "Intercept (ICPT) Up 3.8% Since Earnings Report: Can It Continue?", "Better Know Biotech: 2 Stocks You've Got to Know About", "Madrigal's NASH Study Data Encouraging, Stock Skyrockets", "This Is the Most Undervalued NASH Drug Stock, and Wall Street Is Ignoring It", "3 Top Biotech Stocks to Buy Right Now", "NASH Space in Focus as Galmed (GLMD) Posts Positive Data", "Notable Friday Option Activity: ICPT, JNJ, CELG", "Analysts Anticipate 14% Upside For FXH", "Intercept Pharmaceuticals (ICPT) Shares Cross Above 200 DMA", "Intercept (ICPT) Q1 Loss Narrower Than Expected, Sales Lag", "Why Viking Therapeutics Stock Is On Fire Today", "What's in Store for Intercept (ICPT) This Earnings Season?", "Noteworthy ETF Outflows: XBI, AVXS, ONCE, ICPT", "Gilead (GILD) Presents Encouraging Data on NASH Therapies", "Intercept Reports Phase III Sub-Study Liver Biopsy Data", "Bristol-Myers Collaborates With Harvard Fibrosis Network", "Health Care Sector Update for 04/13/2018: CDNA,PLSE,IPCT,INGN", "Health Care Sector Update for 04/13/2018: PLSE,IPCT,INGN", "Earnings Reaction History: INTERCEPT PHARM, 58.3% Follow-Through Indicator, 4.9% Sensitive", "The Math Shows IYY Can Go To $152", "4 Top Stocks for Investing in Pharma's Next $35 Billion Market", "3 High-Growth Stocks That Could Soar", "Intercept Pharmaceuticals (ICPT) in Focus: Stock Moves 9.9% Higher", "Why Tesla, Marathon Oil, and Intercept Pharmaceuticals Jumped Today", "Health Care Sector Update for 04/05/2018: ICPT,APRI,CNAT", "Notable Tuesday Option Activity: ICPT, ULTA, IFF", "Tuesday 4/10 Insider Buying Report: ICPT, KMX", "2 Cheap Growth Stocks to Buy Right Now", "Analysts Forecast 12% Upside For EQAL", "Intercept (ICPT) Q4 Earnings & Sales Lag on Dull Ocaliva", "Intercept (ICPT) Misses on Q4 Earnings & Sales", "Intercept Starts OCA Trial for NASH Patients With Cirrhosis", "Will Ocaliva Sales Dampen Intercept's (ICPT) Q4 Earnings?", "Noteworthy Thursday Option Activity: XOM, NOW, ICPT", "Intercept (ICPT) Up 6.7% Since Earnings Report: Can It Continue?", "The Primary Reason Intercept Pharmaceuticals, Inc. Was Nearly Halved in 2017", "Intercept (ICPT) Stock Loses Sheen in 2017: What Lies Ahead?", "This Biotech Stock Just Pushed Back A Key Trial Until Early 2018", "7 Life Science Stocks to Buy Today", "Notable Friday Option Activity: ICPT, GILD, CLVS", "Intercept (ICPT) Q3 Loss Narrower Than Expected, Sales Beat", "Intercept Pops After Topping Third-Quarter Sales, Earnings Views", "Biotech Roundup: Who's Popping On Drug, Merger, Earnings News?", "Earnings Reaction History: INTERCEPT PHARM, 50.0% Follow-Through Indicator, 4.4% Sensitive", "Here's Why It's Oca-Liftoff for Intercept Pharmaceuticals Inc.", "Noteworthy Wednesday Option Activity: GPRO, MAR, ICPT", "What's in the Offing for Intercept (ICPT) in Q3 Earnings?", "3 Reasons I've Been Aggressively Buying Intercept Pharmaceuticals", "Bristol-Myers (BMY), TARGET Extend Partnership for NASH Study", "Here's Why Intercept (ICPT) Stock Lost 37% So Far in 2017", "Intercept (ICPT) Reports A Narrower Q3 Loss", "Intercept Dives Along With Ocaliva Prescriptions On FDA Warning", "Why Intercept Pharmaceuticals, Tronox, and MobileIron Jumped Today", "Why These Biotechs Are Leading The Group Near A 21-Month High", "Intercept Pharmaceuticals, Inc. Was Halved in September, but Presents an Intriguing Opportunity", "Sum Up The Parts: XBI Could Be Worth $106", "3 Beaten-Down Biotech Stocks to Buy Right Now", "Will Conatus Liver Disease Candidate Drive Long-Term Growth?", "Bitcoin vs. Biotech: Which Is the Smarter Investment?", "Implied Volatility Surging for Intercept Pharmaceuticals (ICPT) Stock Options", "Biotech Stock Roundup: Amgen Reiterates 2017 Outlook, Intercept Hit by Ocaliva Safety Issues", "Company News For Sep 25, 2017", "Pre-Market Most Active for Sep 25, 2017 : AAPL, GSK, ICPT, VSAR, MT, TLT, RIG, AZN, QQQ, MU, GM, CHK", "Why Intercept Pharmaceuticals Is Sinking Again Today", "Health Care Sector Update for 09/22/2017: ICPT,JUNO,VSAR", "Why Intercept Pharmaceuticals Is Tumbling Today", "Intercept (ICPT) Provides Safety Guidelines For Ocaliva", "Implied Volatility Surging for Intercept Pharmaceuticals (ICPT) Stock Options", "Biotech Stock Roundup: Amgen Reiterates 2017 Outlook, Intercept Hit by Ocaliva Safety Issues", "Company News For Sep 25, 2017", "Pre-Market Most Active for Sep 25, 2017 : AAPL, GSK, ICPT, VSAR, MT, TLT, RIG, AZN, QQQ, MU, GM, CHK", "Is the Sell-Off of Intercept Pharmaceuticals Stock Overblown?", "Intercept Pharmaceuticals Inc (ICPT) Stock Dives on Drug Warning", "Here's Why Intercept Pharmaceuticals Is Tumbling Today", "Why Intercept Pharmaceuticals, Transocean, and U.S. Steel Slumped Today", "Morning Movers: Alcoa Gains on Upgrade; Teva Soars on Sale", "Pre-Market Most Active for Sep 12, 2017 : TEVA, AEG, SAGE, AAPL, TVIX, MT, NOK, AZN, CS, MRNS, ICPT, KWEB", "Why Intercept Pharmaceuticals, Health Insurance Innovations, and Investors Real Estate Trust Slumped Today", "5 of the Most Hated Biotech Stocks on the Market: Are They Buys?", "Analysts Predict 12% Gains Ahead For FBT", "Why Is Intercept Pharmaceuticals (ICPT) Down 3.9% Since the Last Earnings Report?", "ICPT Crosses Above Key Moving Average Level", "Intercept Pharmaceuticals Becomes Oversold (ICPT)", "Morning Movers: Alcoa Gains on Upgrade; Teva Soars on Sale", "Pre-Market Most Active for Sep 12, 2017 : TEVA, AEG, SAGE, AAPL, TVIX, MT, NOK, AZN, CS, MRNS, ICPT, KWEB", "Why Intercept Pharmaceuticals, Health Insurance Innovations, and Investors Real Estate Trust Slumped Today", "5 of the Most Hated Biotech Stocks on the Market: Are They Buys?", "Intercept (ICPT) Reports a Narrower Q2 Loss", "Earnings Reaction History: INTERCEPT PHARM, 41.7% Follow-Through Indicator, 4.7% Sensitive", "Will Conatus Key Candidate Emricasan Drive Long-Term Growth?", "Here's My Top Stock to Buy in August", "Intercept Pharmaceuticals Becomes Oversold (ICPT)", "Notable Two Hundred Day Moving Average Cross - ICPT", "Intercept (ICPT) Posts Narrower-than-Expected Loss in Q2", "Can Horizon Pharma (HZNP) Spring a Surprise in Q2 Earnings?", "Can Intercept (ICPT) Beat Estimates this Earnings Season?", "Can Prothena (PRTA) Deliver a Beat this Earnings Season?", "The Best Stock in New York: Intercept Pharmaceuticals", "What to Expect from Keryx (KERX) this Earnings Season?", "Is a Beat in Store for Alexion (ALXN) this Earnings Season?", "Noteworthy Friday Option Activity: CENX, ICPT, CACC", "Commit To Purchase Intercept Pharmaceuticals At $95, Earn 10.7% Annualized Using Options", "3 Mid-Cap Biotech Stocks That May Be Red-Hot Takeover Candidates", "Will Radius Health (RDUS) Disappoint this Earnings Season?", "Noteworthy Monday Option Activity: ICPT, EMN, C", "Intercept (ICPT) Releases Data from Phase II Flint Trial", "Intercept (ICPT) Down 3.5% Since Earnings Report: Can It Rebound?", "Intercept Pharmaceuticals (ICPT) Looks Good: Stock Adds 5.3% in Session", "3 Stocks With Vertex Pharmaceuticals-Like Return Potential", "Intercept's (ICPT) Liver Drug Ocaliva Approved in Canada", "Notable Wednesday Option Activity: DVN, NEE, ICPT", "Notable Two Hundred Day Moving Average Cross - ICPT", "Intercept (ICPT) Q1 Loss Narrower than Expected, Sales Beat", "Intercept (ICPT) Reports A Narrower Loss in Q1", "Earnings Reaction History: INTERCEPT PHARM, 36.4% Follow-Through Indicator, 4.8% Sensitive", "Noteworthy Thursday Option Activity: SM, ANET, ICPT", "Radius Health (RDUS) Q1 Earnings: What's in Store?", "Is Intercept (ICPT) Poised for a Beat This Earnings Season?", "Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates?", "Knocking on the Door of 2400", "Celgene (CELG) to Post Q1 Earnings: What's in the Cards?", "Should Gilead Sciences Be Worried About Allergan?", "Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?", "Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?", "Novartis (NVS) Q1 Earnings: Will the Stock Disappoint?", "Allergan (AGN) Collaborates with Novartis to Treat NASH", "Commit To Buy Intercept Pharmaceuticals At $80, Earn 9% Annualized Using Options", "Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store?", "Intercept (ICPT) Q4 Loss Wider than Expected, Revenues Beat", "Intercept (ICPT) Reports a Wider Q4 Loss", "Health Care Sector Update for 02/23/2017: ICPT", "Earnings Reaction History: INTERCEPT PHARM, 40.0% Follow-Through Indicator, 4.7% Sensitive", "Intercept (ICPT) to Post Q4 Earnings: What's in the Cards?", "Investors Are Betting Big Against Intercept Pharmaceuticals. Are They Wrong?", "Why Intercept Pharmaceuticals' Latest News Caused the Stock to Jump", "Relative Strength Alert For Intercept Pharmaceuticals", "The Math Shows IYH Can Go To $170", "3 Biotechs Likely to Be Acquired in 2017", "Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug", "Merrimack (MACK) Goes Uphill: Is a Turnaround Likely?", "Should Investors Bet on Gilead Sciences Version 3.0?", "Noteworthy Wednesday Option Activity: PSX, CMG, ICPT", "Noteworthy Friday Option Activity: WEB, ICPT, FCX", "Intercept Pharmaceuticals (ICPT) Jumps: Stock Rises 9.3%", "Commit To Buy Intercept Pharmaceuticals At $70, Earn 7.4% Using Options", "Why Sandstorm Gold, Weis Markets, and Intercept Pharmaceuticals Jumped Today", "Could These 2 Small Biotechs Beat Allergan and Gilead Sciences?", "5 Stocks That Could Make You Rich", "Intercept (ICPT) Ocaliva Gains Conditional Approval in EU", "The Math Shows JKH Can Go To $180", "3 Companies Whose Sales Could Double in 2017", "Intercept (ICPT) Q3 Loss Narrower than Expected, Sales Miss", "Intercept (ICPT) Reports Narrower-Than-Expected Q3 Loss", "Earnings Reaction History: INTERCEPT PHARM, 44.4% Follow-Through Indicator, 5.2% Sensitive", "Noteworthy Wednesday Option Activity: ANGI, ICPT, DBD", "Drug Stocks Q3 Earnings Roster for Nov 3; ICPT, EXEL, AKRX", "Intercept (ICPT) Q3 Earnings Preview: What's in the Cards?", "$40 Billion Opportunity: 3 Biotechs Poised to Dominate", "Charles Payne on Biotech: Biogen Inc (BIIB), Intercept Pharmaceuticals Inc (ICPT)", "Intercept (ICPT) Ocaliva Wins Positive CHMP Opinion for PBC", "Notable Monday Option Activity: ICPT, PG, SEAS", "Analysts Forecast 10% Upside For JKH", "Nonalcoholic Steatohepatitis: What's The Market Opportunity And Who Are The Major Players?", "Nonalcoholic Steatohepatitis (NASH): What's The Market Opportunity And Who Are The Major Players?", "Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain", "Allergan Buys NASH Therapy Maker Tobira at Huge Premium", "Vertex (VRTX) Q3 Earnings: What's in Store for the Stock?", "We Did The Math BBH Can Go To $136", "Intercept (ICPT) Ocaliva Phase III POISE Data Published", "Health Care Sector Update for 08/18/2016: ARWR,ICPT,CERU", "Noteworthy Monday Option Activity: RUBI, ICPT, BWLD", "Intercept (ICPT) Reports Narrower-than-Expected Q2 Loss", "Intercept (ICPT) Posts Narrower-Than-Expected Loss in Q2", "Allergan plc Ordinary Shares: What Is AGN Getting for Its Billion Dollars?", "Looking Beyond Hepatitis C: Here's How Gilead Could Make Another $10 Billion Annually", "We Did The Math BBH Can Go To $136", "Intercept (ICPT) Ocaliva Phase III POISE Data Published", "Health Care Sector Update for 08/18/2016: ARWR,ICPT,CERU", "Noteworthy Monday Option Activity: RUBI, ICPT, BWLD", "Intercept (ICPT) Reports Narrower-than-Expected Q2 Loss", "Pfizer (PFE) Likely to Beat Earnings in Q2 Again", "Earnings Reaction History: INTERCEPT PHARM, 37.5% Follow-Through Indicator, 5.1% Sensitive", "Merck (MRK) Q2 Earnings: Will the Stock Pull a Surprise?", "Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?", "Amgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain?", "4 Rock-Solid, Cheap Biotech Stocks", "3 Stocks That Could Make You Rich", "Noteworthy ETF Outflows: XBI, IONS, ALKS, ICPT", "Why Pier 1 Imports, Intercept Pharmaceuticals, and Costamare Slumped Today", "AbbVie (ABBV) Q2 Earnings: Will the Stock Pull a Surprise?", "Notable Thursday Option Activity: JNJ, NCMI, ICPT", "Health Care Sector Update for 06/30/2016: SYRS,TTHI,OPK,ICPT", "Analysts Anticipate SHE Will Reach $69", "The Zacks Analyst Blog Highlights: Sarepta, Biogen, AbbVie, Intercept and Ionis", "ICPT Makes Bullish Cross Above Critical Moving Average", "Notable Wednesday Option Activity: CKEC, ICPT, GM", "Intercept's (ICPT) Liver Dug Ocaliva Approved by the FDA", "Health Care Sector Update for 06/30/2016: AKER,TTHI,ICPT", "Noteworthy Friday Option Activity: LGF, WSM, ICPT", "The Math Shows EQWM Can Go To $43", "Intercept (ICPT) Q1 Loss Narrower than Expected, Sales Lag", "Earnings Reaction History: INTERCEPT PHARM, 28.6% Follow-Through Indicator, 5.5% Sensitive", "Intercept (ICPT): Stock Likely to Disappoint in Q1 Earnings", "Noteworthy ETF Outflows: XBI, MDVN, NBIX, ICPT", "Synta Stock Up on Merger Deal with Madrigal Pharmaceuticals", "Noteworthy Tuesday Option Activity: ICPT, DY, Z", "The Zacks Analyst Blog Highlights: Intercept, Clovis, AbbVie, Relypsa and Horizon Pharma", "SPDR S&P Biotech ETF Experiences Big Inflow", "How The Parts Add Up: SHE Headed For $68", "Last Week's Best Healthcare ETF", "Intercept's (ICPT) Ocaliva Gets Favorable FDA Panel Vote", "The Zacks Analyst Blog Highlights: Gilead, Regeneron, Medivation and Intercept", "Intercept (ICPT) Up Ahead of Advisory Committee Meeting", "Intercept Pharmaceuticals Reports Phase III Data on Ocaliva", "SPDR S&P Biotech ETF Experiences Big Outflow", "Health Care Sector Update for 04/05/2016: ICPT, ANIP", "Why Lumber Liquidators, SolarCity, and Intercept Pharmaceuticals Jumped Today", "Gilead Descovy Wins FDA Nod, To Buy Nimbus Liver Program", "Noteworthy Monday Option Activity: RGR, LAD, ICPT", "SPDR S&P Biotech (ETF) (XBI) \u2013 The Best Biotech Investment Now", "Intercept (ICPT) Q4 Loss Wider Y/Y, Focus on Liver Drug", "Tuesday's ETF Movers: FBT, DWX", "SPDR S&P Biotech ETF Experiences Big Outflow", "Health Care Sector Update for 04/05/2016: ICPT, ANIP", "Why Lumber Liquidators, SolarCity, and Intercept Pharmaceuticals Jumped Today", "Gilead Descovy Wins FDA Nod, To Buy Nimbus Liver Program", "Noteworthy Monday Option Activity: RGR, LAD, ICPT", "Health Care Sector Update for 02/12/2016: ICPT,XBIO,OPK,TRXC", "Why Intercept Pharmaceuticals Inc is Skyrocketing Today", "Intercept (ICPT) Posts Wider-Than-Expected Loss in Q4", "What's in Store for Intercept (ICPT) This Earnings Season?", "How The Pieces Add Up: IWF Targets $113", "Intercept Pharmaceuticals is Now Oversold (ICPT)", "First Week of September 16th Options Trading For Intercept Pharmaceuticals (ICPT)", "Intercept Pharmaceuticals Enters Oversold Territory (ICPT)", "Intercept Pharmaceuticals Sold Off in December, and Here's Why", "Intercept (ICPT) Down on Delay in FDA's Verdict on Lead Drug", "Noteworthy Friday Option Activity: DISH, CPN, ICPT", "1 Company Gilead Sciences Should Consider Buying Right Now", "How The Pieces Add Up: IWF Targets $113", "Intercept Pharmaceuticals is Now Oversold (ICPT)", "First Week of September 16th Options Trading For Intercept Pharmaceuticals (ICPT)", "Intercept (ICPT) Posts Narrower-than-Expected Loss in Q3", "Epizyme's Q3 Loss Wider-Than-Expected, Pipeline in Focus", "Noteworthy Tuesday Option Activity: SUNE, RMTI, ICPT", "Health Care Sector Update for 12/15/2015: ICPT, KTOV, NEOT, GSK", "2015's Worst Clinical Failures", "Health Care Sector Update for 12/11/2015: LLY, ICPT", "Will Puma Biotechnology (PBYI) Surprise in Q3 Earnings?", "Will Merrimack (MACK) Surprise Estimates in Q3 Earnings?", "Will Intercept (ICPT) Beat Estimates in Q3 Earnings?", "Can Inogen (INGN) Pull a Surprise this Earnings Season?", "Catalyst Pharmaceutical (CPRX): A Peek into Q3 Earnings", "Intercept (ICPT) Posts Narrower-Than-Expected Loss in Q3", "What's in Store for TrovaGene (TROV) Ahead of Q3 Earnings?", "Pre-Market Earnings Report for November 9, 2015 : PCLN, DISH, AMG, ALNY, WWAV, ISIS, COMM, SNI, ICPT, HPT, NRF, NSAM", "Will Puma Biotechnology (PBYI) Surprise in Q3 Earnings?", "Will Merrimack (MACK) Surprise Estimates in Q3 Earnings?", "Will Intercept (ICPT) Beat Estimates in Q3 Earnings?", "Can Inogen (INGN) Pull a Surprise this Earnings Season?", "Catalyst Pharmaceutical (CPRX): A Peek into Q3 Earnings", "Intercept Pharmaceuticals Enters Oversold Territory (ICPT)", "Intercept Pharmaceuticals Files for OCA in U.S. and Europe - Analyst Blog", "Following Hepatitis C, This Could Be the Next Disease Researchers Cure", "Intercept Pharmaceuticals (ICPT) in Focus: Stock Tanks 16.1% - Tale of the Tape", "Intercept Pharmaceuticals Reveals Phase III OCA Study Plan - Analyst Blog", "Why Intercept Pharmaceuticals Shares Are Tumbling", "Health Care Sector Update for 05/19/2015: ICPT, HWAY, ADXS", "Intercept Pharmaceuticals (ICPT): Q2 Earnings Preview - Analyst Blog", "The Zacks Analyst Blog Highlights: Celgene, Juno Therapeutics, Intercept, BioMarin and Sarepta - Press Releases", "Intercept Pharmaceuticals Files for OCA in U.S. and Europe - Analyst Blog", "Following Hepatitis C, This Could Be the Next Disease Researchers Cure", "Intercept Pharmaceuticals (ICPT) in Focus: Stock Tanks 16.1% - Tale of the Tape", "Intercept Pharmaceuticals Reveals Phase III OCA Study Plan - Analyst Blog", "Why Intercept Pharmaceuticals Shares Are Tumbling", "Health Care Sector Update for 05/19/2015: ICPT, HWAY, ADXS", "Intercept Pharmaceuticals (ICPT): Q2 Earnings Preview - Analyst Blog", "Intercept Pharmaceuticals Releases Data on Lead Drug - Analyst Blog", "Notable ETF Inflow Detected - FBT, ICPT, PCYC, CLDX", "Intercept Pharmaceuticals Moves Up In Market Cap Rank, Passing First Solar", "Why Intercept Pharmaceuticals Inc. Exploded Higher in March", "Intercept Pharmaceuticals (ICPT) Loss Narrows in Q4 - Tale of the Tape", "Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog", "FBT, ICPT, NVAX, PCYC: ETF Inflow Alert", "Health Care Sector Update for 03/17/2015: CLDX, BMRN, ICPT", "Monday's ETF Movers: BBH, XOP", "Could This Clinical-Stage Biotech Stock Soar in April?", "3 Biotech Stocks to Buy in March", "Use Options For a Chance To Buy ICPT at a 53% Discount", "Intercept Pharmaceuticals (ICPT) Loss Narrows in Q4 - Tale of the Tape", "Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog", "FBT, ICPT, NVAX, PCYC: ETF Inflow Alert", "Health Care Sector Update for 03/17/2015: CLDX, BMRN, ICPT", "Intercept Pharmaceuticals Inc Breaks Above 200-Day Moving Average - Bullish for ICPT", "Does This Small Biotech Have the Making of a Blockbuster?", "Intercept Pharmaceuticals (ICPT) Jumps: Stock Adds 9.5% - Tale of the Tape", "Why Intercept Pharmaceuticals Inc. Shares Shot Higher By 29% in January", "Monday's ETF Movers: XOP, XBI", "Why Intercept Pharmaceuticals Shares Soared Today", "Intercept Pharmaceuticals' OCA Now Breakthrough Therapy - Analyst Blog", "Pre-Market Earnings Report for March 2, 2015 : ENDP, ICPT, SSYS, BID, PEGI, PTLA, STNG, CORE, VNR, XLRN, EMES, FSS", "Commit To Buy Intercept Pharmaceuticals At $100, Earn 13.3% Using Options", "Monday's ETF Movers: XBI, RYT", "Tuesday's ETF Movers: FBT, GDX", "Why Intercept Pharma (ICPT) Stock Might be a Great Pick - Tale of the Tape", "Did Gilead Sciences Just Buy Its Next Blockbuster Drug?", "Intercept Pharmaceuticals (ICPT) Crumbles: ICPT Falls 9.6% in Session - Tale of the Tape", "3 Biotech Stocks We're Watching Closest Ahead of the JPMorgan Healthcare Conference", "Health Care Sector Update for 01/30/2015: ICPT,QTNT,DNDNQ, VRX", "This ETF Holds Stocks Insiders Want to Own", "Health Care Sector Update for 12/18/2014: ICPT, MRK, CPXX", "Why Intercept Pharmaceuticals Inc. Stock Was Throttled in November", "Will Intercept Pharmaceuticals' (ICPT) Q3 Loss Narrow? - Analyst Blog", "Pre-Market Earnings Report for November 7, 2014 : BAM, HUM, BPL, ICPT, ISIS, STAY, AGIO, ERF, LXP, CTB, SJI, CCOI", "The 5 Best Biotech Stocks in 2014...so far", "Sector Update: Health Stocks Generally Higher Pre-Bell", "Sector Update: Health Care", "Stocks Pull Ahead Into the Close, Ending Higher for Third Consecutive Week", "Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus - Analyst Blog", "Pre-Market Most Active for Aug 12, 2014 : TWTR, XIV, ICPT, BML^J, QQQ, AAPL, SOL, TVIX, MNKD, KATE, GSK, BPL", "Sector Update: Health Care", "Sector Update: Health Care Shares Steady in Early Trade", "3 Hot Ways to Play the Biotechnology Bonanza", "Intercept Pharma (ICPT) Shares Soar on Liver Disease Drug News - Stocks in the News", "Intercept Pharmaceuticals, Inc. Finally Releases FLINT Trial Data", "After-Hours Earnings Report for August 11, 2014 : VTR, NUAN, ICPT, RAX, OPK, MR, MTZ, TRAK, CVG, CZR, HTHT, PDLI", "Why I Love The NASDAQ: The Exchange's Top 10 Performers Year To Date", "Intercept's Obeticholic Acid Gets Fast Track Status - Analyst Blog", "Intercept Sinks on Cholesterol Issue - Analyst Blog", "Wednesday's ETF Movers: GDX, XBI", "Stock Market Today: Russian Sanctions and Oil in Focus 8/12/14 - Stocks in the News", "Sector Update: Healthcares Flat to Lower Pre-Market; Lexicon Soars 20% on Study of Diabetes Treatment", "Sector Update: Healthcares", "Positive Results on Intercept Pharma's OCA - Analyst Blog", "Intercept Pharma Prices 1M Share Offering, Shares Down - Analyst Blog", "3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary", "SPDR S&P Biotech ETF Experiences Big Inflow", "Intercept Sees Weakness in Earnings Result - Analyst Blog", "Tuesday's ETF Movers: XBI, ILF", "Sector Update: Healthcare", "After-Hours Earnings Report for March 14, 2014 : ICPT, INN", "Notable ETF Outflow Detected - XBI, ICPT, ITMN, ARIA", "Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)", "Noteworthy ETF Inflows: XBI, ICPT, ITMN, ARIA", "Precious Metals, Health Care Led Mutual Funds In Feb.", "Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2014?", "Sector Update: Healthcare Shares Flat to Higher Pre-Market; Inovio Dips on Q4 Results", "2 ETFs Riding High on Q4 Earnings Results - ETF News And Commentary", "3 Sector ETFs Surging to Start 2014 - ETF News And Commentary", "Pre-Market Most Active for Jan 13, 2014 : SIRI, BEAM, LULU, TWTR, ALU, BAC, WEN, MS^F, ICPT, FB, VOD, EXPR", "US IPO Recap: Twenty companies file or set terms for IPOs", "Sector Update: Healthcare Shares Higher Pre-Market: Intercept Pharma Up 30%, Adding to Thursday's Big Gains", "Sector Update: Healthcare", "Intercept Pharma (ICPT) Pushes SPDR Biotech ETF Ahead of Rivals - ETF News And Commentary", "The Guide to Surging Biotech ETFs - ETF News And Commentary", "Healthcare Stocks Adding to Earlier Gains; Intercept Pharmaceuticals Extends Rally Another Day, Rising 60%", "Sector Update: Healthcare", "Pre-Market Most Active for Jan 9, 2014 : ALU, JCP, NOK, AV, BAC, C^K, ICPT, SQNM, FB, QQQ, ACHN, BBBY", "Healthcare Stocks Adding to Earlier Gains; Big Rally by Intercept Pharma Also Raising Peers", "Sector Update: Healthcare", "Intercept to Provide Update on Pipeline - Analyst Blog", "Intercept Pharmaceuticals Inc. (ICPT) Enters Overbought Territory - Tale of the Tape", "No Jobs? No Problem!", "Weeky CFO Sells Highlight: ADBE, HAE, WAGE, OVTI, ICPT", "PLL Expands into Research - Analyst Blog", "Shutterstock prices IPO at $17, above the range", "Intercept Pharmaceuticals increases deal size, prices IPO at $15, at high end of the range", "Intercept Pharmaceuticals sets IPO terms", "Insiders Sell Shares of Dolby Labs and Intercept Pharma; QTS Realty Trust Sees a Purchase"], "Elapsed Time": ["JUN 18, 2020", "JUN 17, 2020", "JUN 6, 2020", "JUN 3, 2020", "JUN 2, 2020", "JUN 1, 2020", "MAY 22, 2020", "MAY 22, 2020", "JUN 18, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 16, 2020", "MAY 22, 2020", "MAY 12, 2020", "MAY 12, 2020", "MAY 11, 2020", "MAY 11, 2020", "MAY 7, 2020", "MAY 6, 2020", "MAY 4, 2020", "MAY 12, 2020", "APR 17, 2020", "APR 12, 2020", "APR 9, 2020", "APR 9, 2020", "APR 8, 2020", "APR 8, 2020", "APR 5, 2020", "APR 17, 2020", "MAR 27, 2020", "MAR 26, 2020", "MAR 23, 2020", "MAR 18, 2020", "MAR 9, 2020", "FEB 25, 2020", "FEB 25, 2020", "MAR 30, 2020", "FEB 24, 2020", "FEB 18, 2020", "FEB 5, 2020", "JAN 30, 2020", "JAN 23, 2020", "JAN 23, 2020", "JAN 23, 2020", "FEB 24, 2020", "JAN 22, 2020", "JAN 13, 2020", "JAN 10, 2020", "JAN 8, 2020", "DEC 27, 2019", "DEC 26, 2019", "DEC 23, 2019", "JAN 23, 2020", "DEC 10, 2019", "DEC 9, 2019", "DEC 6, 2019", "NOV 29, 2019", "NOV 26, 2019", "NOV 25, 2019", "NOV 11, 2019", "DEC 17, 2019", "NOV 6, 2019", "NOV 5, 2019", "OCT 23, 2019", "OCT 16, 2019", "OCT 11, 2019", "OCT 11, 2019", "OCT 8, 2019", "NOV 10, 2019", "AUG 26, 2019", "AUG 26, 2019", "AUG 8, 2019", "AUG 7, 2019", "AUG 7, 2019", "JUL 24, 2019", "SEP 21, 2019", "JUL 1, 2019", "JUN 30, 2019", "MAY 30, 2019", "MAY 23, 2019", "MAY 19, 2019", "APR 27, 2019", "APR 19, 2019", "JUL 19, 2019", "APR 18, 2019", "APR 17, 2019", "APR 17, 2019", "APR 16, 2019", "APR 16, 2019", "APR 16, 2019", "APR 15, 2019", "APR 18, 2019", "APR 18, 2019", "APR 17, 2019", "APR 17, 2019", "APR 11, 2019", "APR 11, 2019", "APR 11, 2019", "APR 11, 2019", "APR 12, 2019", "APR 11, 2019", "APR 10, 2019", "APR 10, 2019", "APR 2, 2019", "APR 2, 2019", "APR 1, 2019", "MAR 31, 2019", "APR 11, 2019", "APR 11, 2019", "APR 10, 2019", "APR 10, 2019", "MAR 6, 2019", "MAR 1, 2019", "MAR 1, 2019", "FEB 28, 2019", "MAR 30, 2019", "MAR 22, 2019", "MAR 20, 2019", "FEB 27, 2019", "FEB 27, 2019", "FEB 22, 2019", "FEB 21, 2019", "FEB 21, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 28, 2019", "FEB 27, 2019", "FEB 27, 2019", "FEB 22, 2019", "FEB 21, 2019", "FEB 21, 2019", "FEB 21, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 21, 2019", "FEB 19, 2019", "FEB 19, 2019", "FEB 19, 2019", "FEB 19, 2019", "FEB 19, 2019", "FEB 19, 2019", "FEB 19, 2019", "FEB 19, 2019", "FEB 5, 2019", "JAN 30, 2019", "JAN 29, 2019", "JAN 25, 2019", "JAN 11, 2019", "JAN 8, 2019", "JAN 7, 2019", "FEB 6, 2019", "FEB 5, 2019", "JAN 30, 2019", "JAN 29, 2019", "JAN 25, 2019", "DEC 13, 2018", "DEC 13, 2018", "DEC 31, 2018", "DEC 28, 2018", "DEC 28, 2018", "NOV 15, 2018", "NOV 13, 2018", "NOV 12, 2018", "NOV 8, 2018", "NOV 1, 2018", "DEC 9, 2018", "OCT 31, 2018", "OCT 27, 2018", "OCT 27, 2018", "OCT 25, 2018", "OCT 19, 2018", "OCT 17, 2018", "OCT 16, 2018", "OCT 31, 2018", "OCT 16, 2018", "OCT 11, 2018", "OCT 3, 2018", "OCT 2, 2018", "OCT 2, 2018", "SEP 28, 2018", "SEP 26, 2018", "OCT 16, 2018", "SEP 24, 2018", "SEP 20, 2018", "SEP 18, 2018", "SEP 17, 2018", "SEP 14, 2018", "SEP 12, 2018", "SEP 11, 2018", "SEP 25, 2018", "SEP 5, 2018", "AUG 17, 2018", "AUG 15, 2018", "AUG 14, 2018", "AUG 13, 2018", "AUG 9, 2018", "AUG 6, 2018", "SEP 7, 2018", "AUG 3, 2018", "AUG 2, 2018", "AUG 2, 2018", "JUL 30, 2018", "JUL 27, 2018", "JUL 27, 2018", "JUL 26, 2018", "AUG 3, 2018", "AUG 3, 2018", "AUG 2, 2018", "AUG 2, 2018", "JUL 30, 2018", "JUL 12, 2018", "JUN 29, 2018", "JUN 26, 2018", "JUL 23, 2018", "JUN 18, 2018", "JUN 14, 2018", "JUN 13, 2018", "JUN 12, 2018", "JUN 7, 2018", "JUN 1, 2018", "JUN 1, 2018", "JUN 26, 2018", "JUN 18, 2018", "JUN 14, 2018", "MAY 18, 2018", "MAY 10, 2018", "MAY 9, 2018", "MAY 8, 2018", "MAY 31, 2018", "APR 30, 2018", "APR 18, 2018", "APR 16, 2018", "APR 16, 2018", "APR 13, 2018", "APR 13, 2018", "APR 13, 2018", "MAY 8, 2018", "APR 9, 2018", "APR 8, 2018", "APR 6, 2018", "APR 6, 2018", "APR 5, 2018", "APR 5, 2018", "APR 3, 2018", "APR 10, 2018", "MAR 8, 2018", "MAR 8, 2018", "FEB 15, 2018", "FEB 14, 2018", "FEB 13, 2018", "FEB 12, 2018", "FEB 1, 2018", "MAR 16, 2018", "JAN 12, 2018", "DEC 29, 2017", "DEC 28, 2017", "NOV 14, 2017", "NOV 10, 2017", "NOV 2, 2017", "NOV 1, 2017", "FEB 1, 2018", "NOV 1, 2017", "NOV 1, 2017", "NOV 1, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 13, 2017", "OCT 12, 2017", "NOV 1, 2017", "OCT 6, 2017", "OCT 5, 2017", "OCT 4, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 2, 2017", "SEP 28, 2017", "OCT 8, 2017", "SEP 26, 2017", "SEP 26, 2017", "SEP 25, 2017", "SEP 25, 2017", "SEP 22, 2017", "SEP 22, 2017", "SEP 21, 2017", "SEP 27, 2017", "SEP 26, 2017", "SEP 26, 2017", "SEP 25, 2017", "SEP 14, 2017", "SEP 13, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 21, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 1, 2017", "AUG 31, 2017", "AUG 31, 2017", "AUG 30, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 1, 2017", "JUL 31, 2017", "JUL 31, 2017", "AUG 21, 2017", "AUG 14, 2017", "AUG 9, 2017", "AUG 1, 2017", "AUG 1, 2017", "JUL 31, 2017", "JUL 25, 2017", "JUL 28, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 20, 2017", "JUL 7, 2017", "JUL 6, 2017", "JUL 5, 2017", "JUL 25, 2017", "JUN 19, 2017", "JUN 13, 2017", "JUN 12, 2017", "JUN 5, 2017", "JUN 3, 2017", "MAY 29, 2017", "MAY 24, 2017", "JUL 3, 2017", "MAY 5, 2017", "MAY 4, 2017", "MAY 4, 2017", "MAY 4, 2017", "MAY 1, 2017", "APR 28, 2017", "APR 25, 2017", "MAY 11, 2017", "APR 24, 2017", "APR 23, 2017", "APR 21, 2017", "APR 21, 2017", "APR 20, 2017", "APR 19, 2017", "APR 6, 2017", "APR 25, 2017", "FEB 24, 2017", "FEB 23, 2017", "FEB 23, 2017", "FEB 23, 2017", "FEB 21, 2017", "FEB 17, 2017", "FEB 11, 2017", "APR 5, 2017", "FEB 7, 2017", "JAN 22, 2017", "JAN 18, 2017", "JAN 17, 2017", "JAN 14, 2017", "JAN 11, 2017", "FEB 10, 2017", "DEC 29, 2016", "DEC 28, 2016", "DEC 28, 2016", "DEC 17, 2016", "DEC 16, 2016", "DEC 15, 2016", "DEC 1, 2016", "JAN 7, 2017", "NOV 4, 2016", "NOV 3, 2016", "NOV 3, 2016", "NOV 2, 2016", "NOV 2, 2016", "NOV 1, 2016", "OCT 31, 2016", "NOV 29, 2016", "OCT 17, 2016", "OCT 3, 2016", "SEP 30, 2016", "SEP 29, 2016", "SEP 29, 2016", "SEP 21, 2016", "SEP 21, 2016", "OCT 20, 2016", "AUG 26, 2016", "AUG 18, 2016", "AUG 18, 2016", "AUG 15, 2016", "AUG 8, 2016", "AUG 4, 2016", "SEP 20, 2016", "AUG 30, 2016", "AUG 26, 2016", "AUG 18, 2016", "AUG 18, 2016", "AUG 15, 2016", "AUG 8, 2016", "JUL 29, 2016", "AUG 4, 2016", "JUL 26, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 16, 2016", "JUL 9, 2016", "JUL 1, 2016", "JUN 30, 2016", "JUL 26, 2016", "JUN 30, 2016", "JUN 30, 2016", "JUN 13, 2016", "JUN 2, 2016", "JUN 1, 2016", "JUN 1, 2016", "MAY 30, 2016", "JUN 30, 2016", "MAY 13, 2016", "MAY 12, 2016", "MAY 6, 2016", "MAY 5, 2016", "MAY 3, 2016", "APR 21, 2016", "APR 15, 2016", "MAY 24, 2016", "APR 14, 2016", "APR 13, 2016", "APR 11, 2016", "APR 8, 2016", "APR 8, 2016", "APR 7, 2016", "APR 6, 2016", "APR 15, 2016", "APR 5, 2016", "APR 5, 2016", "APR 5, 2016", "APR 5, 2016", "APR 4, 2016", "MAR 24, 2016", "FEB 24, 2016", "APR 5, 2016", "APR 5, 2016", "APR 5, 2016", "APR 5, 2016", "APR 5, 2016", "APR 4, 2016", "FEB 12, 2016", "FEB 12, 2016", "FEB 23, 2016", "FEB 19, 2016", "FEB 3, 2016", "FEB 2, 2016", "JAN 22, 2016", "JAN 11, 2016", "JAN 7, 2016", "DEC 18, 2015", "FEB 12, 2016", "FEB 6, 2016", "FEB 3, 2016", "FEB 2, 2016", "JAN 22, 2016", "NOV 10, 2015", "NOV 10, 2015", "NOV 10, 2015", "DEC 15, 2015", "DEC 12, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 9, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 6, 2015", "SEP 24, 2015", "JUN 30, 2015", "MAY 21, 2015", "MAY 20, 2015", "MAY 20, 2015", "MAY 19, 2015", "MAY 19, 2015", "AUG 4, 2015", "JUL 2, 2015", "JUN 30, 2015", "MAY 21, 2015", "MAY 20, 2015", "MAY 20, 2015", "MAY 19, 2015", "MAY 19, 2015", "AUG 4, 2015", "APR 24, 2015", "APR 22, 2015", "APR 20, 2015", "MAR 10, 2015", "MAR 2, 2015", "FEB 28, 2015", "FEB 27, 2015", "MAR 17, 2015", "MAR 16, 2015", "MAR 12, 2015", "MAR 11, 2015", "MAR 10, 2015", "MAR 2, 2015", "FEB 28, 2015", "FEB 27, 2015", "MAR 17, 2015", "FEB 23, 2015", "FEB 7, 2015", "FEB 6, 2015", "FEB 5, 2015", "FEB 2, 2015", "JAN 30, 2015", "JAN 30, 2015", "FEB 27, 2015", "JAN 26, 2015", "JAN 26, 2015", "JAN 13, 2015", "JAN 12, 2015", "JAN 10, 2015", "JAN 7, 2015", "JAN 5, 2015", "JAN 5, 2015", "JAN 2, 2015", "DEC 18, 2014", "DEC 1, 2014", "NOV 6, 2014", "NOV 6, 2014", "SEP 26, 2014", "NOV 7, 2014", "NOV 7, 2014", "NOV 7, 2014", "AUG 13, 2014", "AUG 12, 2014", "AUG 12, 2014", "AUG 12, 2014", "SEP 17, 2014", "AUG 12, 2014", "AUG 11, 2014", "AUG 11, 2014", "JUN 19, 2014", "MAY 29, 2014", "MAY 21, 2014", "APR 23, 2014", "AUG 12, 2014", "APR 14, 2014", "APR 14, 2014", "APR 14, 2014", "APR 8, 2014", "MAR 24, 2014", "MAR 21, 2014", "MAR 18, 2014", "APR 22, 2014", "MAR 17, 2014", "MAR 14, 2014", "MAR 13, 2014", "MAR 13, 2014", "MAR 5, 2014", "MAR 4, 2014", "FEB 12, 2014", "MAR 17, 2014", "FEB 5, 2014", "JAN 20, 2014", "JAN 13, 2014", "JAN 13, 2014", "JAN 10, 2014", "JAN 10, 2014", "JAN 10, 2014", "FEB 11, 2014", "JAN 10, 2014", "JAN 10, 2014", "JAN 9, 2014", "JAN 9, 2014", "JAN 9, 2014", "JAN 6, 2014", "DEC 16, 2013", "JAN 10, 2014", "JUN 24, 2013", "MAR 6, 2013", "OCT 10, 2012", "OCT 10, 2012", "SEP 27, 2012", "OCT 18, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-madrigal-pharmaceuticals-2020-06-18", "https://www.nasdaq.com/articles/is-intercept-pharmaceuticals-stock-a-buy-2020-06-17", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-june-2020-06-06", "https://www.nasdaq.com/articles/5-top-stocks-to-buy-in-june-2020-06-03", "https://www.nasdaq.com/articles/is-acadia-pharmaceuticals-a-buy-2020-06-02", "https://www.nasdaq.com/articles/heres-my-single-best-investment-idea-for-june-2020-06-01", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-22-2020%3A-aqstxspanavbxspaicpt-2020-05-22", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-shares-fall-13-after-fda-delays-an-advisory-committee-meeting", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-madrigal-pharmaceuticals-2020-06-18", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-22-2020%3A-navbxspaicpt-2020-05-22", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-is-plunging-today-2020-05-22", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-abbott-tetraphase-pharma-hpe-2020-05-22", "https://www.nasdaq.com/articles/stock-alert%3A-intercept-pharmaceuticals-down-14-2020-05-22", "https://www.nasdaq.com/articles/intercept%3A-fda-postpones-meeting-on-nda-for-liver-fibrosis-treatment-stock-down-2020-05-22", "https://www.nasdaq.com/articles/got-%241000-here-are-the-smartest-etfs-to-buy-and-hold-for-5-years-2020-05-22", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-gilead-sciences-2020-05-16", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-liveramp-t2-biosystems-foot-locker-2020-05-22", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-datadog-novavax-cymabay-therapeutics-2020-05-12", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-cymabay-therapeutics-california-resources-novavax-2020-05-12", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc-icpt-q1-2020-earnings-call-transcript-2020-05-11", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-stock-caught-fire-in-april-2020-05-11", "https://www.nasdaq.com/articles/june-26th-options-now-available-for-intercept-pharmaceuticals-icpt-2020-05-07", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-gm-axcella-beyond-meat-smiledirect-2020-05-06", "https://www.nasdaq.com/articles/3-top-stocks-that-will-make-you-richer-in-may-and-beyond-2020-05-04", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-helius-medical-datadog-novavax-2020-05-12", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-goog-ma-icpt-2020-04-17", "https://www.nasdaq.com/articles/the-3-best-small-cap-stocks-to-buy-with-your-stimulus-check-2020-04-12", "https://www.nasdaq.com/articles/will-fda-approve-first-nash-drug-in-2020-2020-04-09", "https://www.nasdaq.com/articles/2-dirt-cheap-growth-stocks-to-buy-now-2020-04-09", "https://www.nasdaq.com/articles/first-week-of-may-8th-options-trading-for-intercept-pharmaceuticals-icpt-2020-04-08", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-stock-got-crushed-in-march-2020-04-08", "https://www.nasdaq.com/articles/30-top-stocks-and-funds-to-beat-the-covid-19-bear-market-2020-04-05", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-icpt-2020-04-17", "https://www.nasdaq.com/articles/u.s.-now-has-most-virus-cases-bsgm-to-develop-covid-19-drug-fda-nod-for-bmy-2020-03-27", "https://www.nasdaq.com/articles/3-small-cap-stocks-to-buy-following-the-covid-19-crash-2020-03-26", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-is-now-oversold-icpt-2020-03-23", "https://www.nasdaq.com/articles/will-covid-19-derail-new-drugs-2020-03-18", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-madrigal-pharmaceuticals-2020-03-09", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc-icpt-q4-2019-earnings-call-transcript-2020-02-25", "https://www.nasdaq.com/articles/is-intercept-pharmaceuticals-stock-a-buy-2020-02-25", "https://www.nasdaq.com/articles/how-the-pieces-add-up%3A-iyh-targets-%24234-2020-03-30", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-chng-eri-icpt-2020-02-24", "https://www.nasdaq.com/articles/is-viking-therapeutics-stock-a-buy-2020-02-18", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-icpt-nvro-onb-2020-02-05", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-gilead-sciences-2020-01-30", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-enters-oversold-territory-icpt-2020-01-23", "https://www.nasdaq.com/articles/interesting-icpt-put-and-call-options-for-september-18th-2020-01-23", "https://www.nasdaq.com/articles/where-will-intercept-pharmaceuticals-be-in-5-years-2020-01-23", "https://www.nasdaq.com/articles/ngm-biopharmaceuticals-reports-a-successful-nash-trial-2020-02-24", "https://www.nasdaq.com/articles/2-mid-cap-biotech-stocks-to-buy-right-now-2020-01-22", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-mlm-team-icpt-2020-01-13", "https://www.nasdaq.com/articles/3-biotech-stocks-to-bank-on-for-buyouts-in-2020-2020-01-10", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-experiences-big-outflow-2020-01-08", "https://www.nasdaq.com/articles/xbi-icpt-sgen-alny%3A-large-inflows-detected-at-etf-2019-12-27", "https://www.nasdaq.com/articles/analysts-expect-17-gains-ahead-for-fbt-2019-12-26", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-arna-mygn-icpt-2019-12-23", "https://www.nasdaq.com/articles/2-small-cap-biotech-stocks-to-watch-in-2020-2020-01-23", "https://www.nasdaq.com/articles/heres-why-intercept-pharmaceuticals-stock-rose-48.9-in-november-2019-12-10", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-v-icpt-ayi-2019-12-09", "https://www.nasdaq.com/articles/january-2020-options-now-available-for-intercept-pharmaceuticals-icpt-2019-12-06", "https://www.nasdaq.com/articles/these-3-biotech-stocks-could-more-than-double-in-2020-says-wedbush-2019-11-29", "https://www.nasdaq.com/articles/ccxi-is-red-hot-zgnx-on-watch-fda-snubs-admp-2019-11-26", "https://www.nasdaq.com/articles/fbt-qgen-sgen-icpt%3A-large-outflows-detected-at-etf-2019-11-25", "https://www.nasdaq.com/articles/20-stocks-that-could-double-your-money-in-2020-2019-11-11", "https://www.nasdaq.com/articles/drugs-that-missed-key-goals-in-phase-iii-trials-2019-12-17", "https://www.nasdaq.com/articles/up-19.2-is-viking-therapeutics-stock-still-a-buy-2019-11-06", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc-icpt-q3-2019-earnings-call-transcript-2019-11-05", "https://www.nasdaq.com/articles/3-things-to-watch-from-the-pharmaceutical-industrys-liver-meeting-2019-10-23", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-madrigal-pharmaceuticals-2019-10-16", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-lvs-icpt-mpc-2019-10-11", "https://www.nasdaq.com/articles/will-the-pace-of-ma-pick-up-following-the-biotech-sectors-pounding-2019-10-11", "https://www.nasdaq.com/articles/will-insiders-be-tempted-to-buy-more-icpt-at-the-new-52-week-low-2019-10-08", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-or-genfit-2019-11-10", "https://www.nasdaq.com/articles/monday-8-26-insider-buying-report%3A-icpt-dfin-2019-08-26", "https://www.nasdaq.com/articles/3-small-cap-stocks-with-big-cap-potential-2019-08-26", "https://www.nasdaq.com/articles/add-up-the-pieces%3A-rxl-could-be-worth-%24113-2019-08-08", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc-icpt-q2-2019-earnings-call-transcript-2019-08-08", "https://www.nasdaq.com/articles/what-youll-want-to-know-about-intercept-pharmaceuticals-q2-update-2019-08-07", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-in-july-2019-07-24", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-gilead-sciences-2019-09-21", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-icpt-lmt-rdnt-2019-07-01", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-cv-sciences-2019-06-30", "https://www.nasdaq.com/articles/7-stocks-to-buy-for-monster-growth-2019-05-30", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2019-05-23", "https://www.nasdaq.com/articles/better-buy%3A-intercept-pharmaceuticals-vs.-gilead-sciences-2019-05-19", "https://www.nasdaq.com/articles/2-reasons-gilead-sciences-nash-program-could-bounce-back-2019-04-27", "https://www.nasdaq.com/articles/5-top-pharmaceutical-stocks-buy-2019-2019-04-19", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-enters-oversold-territory-icpt-2019-07-19", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-gm-gild-icpt-2019-04-18-0", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-becomes-oversold-icpt-2019-04-17", "https://www.nasdaq.com/articles/may-31st-options-now-available-intercept-pharmaceuticals-icpt-2019-04-17", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-april-2019-04-16", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-experiences-big-outflow-2019-04-16", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-april-2019-04-16-0", "https://www.nasdaq.com/articles/gilead-to-collaborate-with-novo-nordisk-for-nash-treatment-2019-04-15-0", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-gm-gild-icpt-2019-04-18", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-gm-gild-icpt-2019-04-18-0", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-becomes-oversold-icpt-2019-04-17", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-weight-watchers-international-and-canopy-growth-slumped", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-11-2019%3A-jnjicptinntsgen-2019-04-11", "https://www.nasdaq.com/articles/icpt-makes-notable-cross-below-critical-moving-average-2019-04-11", "https://www.nasdaq.com/articles/why-intercepts-success-was-big-disappointment-2019-04-11", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-weight-watchers-international-and-canopy-growth-slumped-0", "https://www.nasdaq.com/articles/fridays-etf-unusual-volume-fny-2019-04-12", "https://www.nasdaq.com/articles/health-care-sector-update-04112019-icptinntsgen-2019-04-11", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-icpt-mhk-panw-2019-04-10", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-icpt-mhk-panw-2019-04-10-0", "https://www.nasdaq.com/articles/better-buy-intercept-pharmaceuticals-vs-gilead-sciences-2019-04-02", "https://www.nasdaq.com/articles/better-buy-intercept-pharmaceuticals-vs-gilead-sciences-2019-04-02-0", "https://www.nasdaq.com/articles/novartis-nvs-to-acquire-subsidiary-of-ifm-therapeutics-2019-04-01-0", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2019-03-31", "https://www.nasdaq.com/articles/health-care-sector-update-04112019-jnjicptinntsgen-2019-04-11-0", "https://www.nasdaq.com/articles/health-care-sector-update-04112019-icptinntsgen-2019-04-11", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-icpt-mhk-panw-2019-04-10", "https://www.nasdaq.com/articles/7-small-cap-stocks-that-make-the-grade-2019-03-15", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-stock-hit-skids-february-2019-03-06", "https://www.nasdaq.com/articles/intercept-icpt-up-on-q4-revenue-beat-nash-study-in-focus-2019-03-01", "https://www.nasdaq.com/articles/notable-friday-option-activity-icpt-c-cbs-2019-03-01", "https://www.nasdaq.com/articles/icpt-makes-bullish-cross-above-critical-moving-average-2019-02-28", "https://www.nasdaq.com/articles/2-biotechs-big-dates-april-2019-03-30", "https://www.nasdaq.com/articles/conatus-cnat-declines-on-failure-of-nash-fibrosis-study-2019-03-22", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-q4-2018-earnings-conference-call-transcript-2019-02-28", "https://www.nasdaq.com/articles/3-top-mid-cap-stocks-buy-right-now-2019-02-27", "https://www.nasdaq.com/articles/viking-therapeutics-buy-2019-02-27", "https://www.nasdaq.com/articles/3-top-us-stocks-watch-february-2019-02-22", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-may-report-negative-earnings%3A-know-the-trend-ahead-of-next", "https://www.nasdaq.com/articles/35-billion-market-positive-clinical-trial-yet-shares-are-down-2019-02-21", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-stock-jumping-today-2019-02-28", "https://www.nasdaq.com/articles/interesting-icpt-put-options-april-12th-2019-02-28", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-q4-2018-earnings-conference-call-transcript-2019-02-28", "https://www.nasdaq.com/articles/3-top-mid-cap-stocks-buy-right-now-2019-02-27", "https://www.nasdaq.com/articles/viking-therapeutics-buy-2019-02-27", "https://www.nasdaq.com/articles/3-top-us-stocks-watch-february-2019-02-22", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-may-report-negative-earnings%3A-know-the-trend-ahead-of-next", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-intercept-gilead-vertex-alkermes-and-clovis-2019-02-21", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-imdz-ttec-icpt-2019-02-21", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-investors-strap-wild-ride-2019-02-20", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-icpt-strong-on-nash-drug-data-collaborations-more-2019-02-20", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-surges%3A-stock-moves-6.1-higher-2019-02-20", "https://www.nasdaq.com/articles/intercept-reports-positive-top-line-data-for-nash-shares-up-2019-02-20", "https://www.nasdaq.com/articles/heres-why-intercept-pharmaceuticals-changed-course-today-2019-02-20", "https://www.nasdaq.com/articles/wednesdays-etf-movers-xme-xbi-2019-02-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-intercept-gilead-vertex-alkermes-and-clovis-2019-02-21", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-higher-walmart-tops-q4-expectations-2019-02-19", "https://www.nasdaq.com/articles/health-care-sector-update-02192019-icpt-mdt-neo-jnj-pfe-abt-mrk-amgn-2019-02-19", "https://www.nasdaq.com/articles/wall-street-tips-lower-ahead-opening-bell-us-china-trade-talks-resume-2019-02-19", "https://www.nasdaq.com/articles/us-futures-slump-us-china-trade-talks-resume-2019-02-19", "https://www.nasdaq.com/articles/intercepts-drug-patients-liver-fibrosis-due-nash-meets-main-goal-2019-02-19", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-pge-and-superior-energy-services-jumped-today-2019-02-19", "https://www.nasdaq.com/articles/consumer-sector-update-02192019-morcndticptclvsalks-2019-02-19", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-stock-soaring-today-2019-02-19", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-sq-icpt-ctrl-2019-02-05", "https://www.nasdaq.com/articles/intercept-pharma-icpt-stock-upgraded-market-outperform-2019-01-30-0", "https://www.nasdaq.com/articles/biggest-biotech-binary-event-2019-just-around-corner-2019-01-29", "https://www.nasdaq.com/articles/analysts-anticipate-iyh-will-reach-216-2019-01-25", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-intercept-pharmaceuticals-icpt-stock-2019-01", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-btu-tgt-icpt-2019-01-08", "https://www.nasdaq.com/articles/gilead-gild-collaborates-with-yuhan-for-nash-candidates-2019-01-07", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-may-report-negative-earnings%3A-know-the-trend-ahead-of-0", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-sq-icpt-ctrl-2019-02-05", "https://www.nasdaq.com/articles/intercept-pharma-icpt-stock-upgraded-market-outperform-2019-01-30-0", "https://www.nasdaq.com/articles/biggest-biotech-binary-event-2019-just-around-corner-2019-01-29", "https://www.nasdaq.com/articles/analysts-anticipate-iyh-will-reach-216-2019-01-25", "https://www.nasdaq.com/articles/10-best-stocks-buy-finish-out-2018-2018-12-13", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-bby-icpt-toca-2018-12-13", "https://www.nasdaq.com/articles/mondays-etf-movers-fbt-oih-2018-12-31", "https://www.nasdaq.com/articles/my-top-portfolio-holdings-2019-2018-12-28", "https://www.nasdaq.com/articles/intercept-icpt-benefits-from-ocalivas-recovery-in-2018-2018-12-28", "https://www.nasdaq.com/articles/iyhs-underlying-holdings-imply-15-gain-potential-2018-11-15", "https://www.nasdaq.com/articles/why-viking-therapeutics-stock-bolting-higher-today-2018-11-13", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-inc-stock-broke-down-october-2018-11-12", "https://www.nasdaq.com/articles/december-28th-options-now-available-intercept-pharmaceuticals-icpt-2018-11-08", "https://www.nasdaq.com/articles/intercept-icpt-gains-on-earnings-and-revenue-beat-in-q3-2018-11-01", "https://www.nasdaq.com/articles/better-buy-intercept-pharmaceuticals-vs-genfit-2018-12-09", "https://www.nasdaq.com/articles/health-care-sector-update-10312018-icptnuvaexasclvs-2018-10-31", "https://www.nasdaq.com/articles/better-buy-intercept-pharmaceuticals-inc-vs-madrigal-pharmaceuticals-2018-10-27", "https://www.nasdaq.com/articles/where-will-gilead-sciences-inc-be-5-years-2018-10-27", "https://www.nasdaq.com/articles/3-top-mid-cap-stocks-buy-immediately-2018-10-25", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-sam-vfc-icpt-2018-10-19", "https://www.nasdaq.com/articles/5-beaten-down-biotech-stocks-pick-wreckage-2018-10-17", "https://www.nasdaq.com/articles/fbt-tech-iqv-icpt-etf-inflow-alert-2018-10-16", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-reports-q3-loss-tops-revenue-estimates-2018-10-31", "https://www.nasdaq.com/articles/can-tiny-biotech-revolutionize-35-billion-market-2018-10-16", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-inc-stock-raced-higher-september-2018-10-11", "https://www.nasdaq.com/articles/3-small-biotech-stocks-52-week-highs-are-they-buys-2018-10-03", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-icpt-cacc-dal-2018-10-02", "https://www.nasdaq.com/articles/health-care-sector-update-10022018-vstmmmsijnjicpt-2018-10-02", "https://www.nasdaq.com/articles/first-week-november-16th-options-trading-intercept-pharmaceuticals-2018-09-28", "https://www.nasdaq.com/articles/5-biotech-stocks-play-sectors-next-big-trend-nash-2018-09-26", "https://www.nasdaq.com/articles/forget-gilead-sciences-intercept-pharmaceuticals-inc-better-growth-stock-2018-10-16", "https://www.nasdaq.com/articles/notable-monday-option-activity-icpt-tpx-x-2018-09-24", "https://www.nasdaq.com/articles/viking-therapeutics-best-nash-stock-buy-now-2018-09-20", "https://www.nasdaq.com/articles/viking-therapeutics-and-madrigal-pharmaceuticals-are-racing-finish-line-nash-2018-09-18", "https://www.nasdaq.com/articles/xbi-icpt-srpt-regn-large-outflows-detected-etf-2018-09-17", "https://www.nasdaq.com/articles/insiders-were-right-icpt-makes-new-52-week-high-2018-09-14", "https://www.nasdaq.com/articles/3-top-stocks-investing-pharmas-next-35-billion-market-2018-09-12", "https://www.nasdaq.com/articles/heres-why-intercept-pharmaceuticals-jumped-227-august-2018-09-11", "https://www.nasdaq.com/articles/xbi-icpt-srpt-regn-etf-outflow-alert-2018-09-25", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-icpt-lulu-hds-2018-09-05", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc-buy-2018-08-17", "https://www.nasdaq.com/articles/health-care-sector-update-08152018-icptcgcweedtostzllyears-2018-08-15", "https://www.nasdaq.com/articles/iyhs-holdings-imply-10-gain-potential-2018-08-14", "https://www.nasdaq.com/articles/xbi-icpt-regn-hrtx-large-outflows-detected-etf-2018-08-13", "https://www.nasdaq.com/articles/2-growth-stocks-could-make-you-rich-2018-08-09", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-stock-moving-higher-today-2018-08-06", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xbi-icpt-srpt-hrtx-2018-09-07", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-cmpr-ely-icpt-2018-08-03", "https://www.nasdaq.com/articles/xbi-hrtx-icpt-regn-large-inflows-detected-etf-2018-08-02", "https://www.nasdaq.com/articles/intercept-icpt-q2-loss-narrower-expected-2018-08-02", "https://www.nasdaq.com/articles/whats-in-store-for-intercept-icpt-this-earnings-season-2018-07-30", "https://www.nasdaq.com/articles/can-appfolio-appf-keep-earnings-streak-alive-in-q2-2018-07-27", "https://www.nasdaq.com/articles/whats-in-the-store-for-ipg-photonics-ipgp-in-q2-earnings-2018-07-27", "https://www.nasdaq.com/articles/whats-in-the-offing-for-castlight-cslt-in-q2-earnings-2018-07-26", "https://www.nasdaq.com/articles/intercept-icpt-gains-on-solid-q2-results-ocaliva-recovers-2018-08-03", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-cmpr-ely-icpt-2018-08-03", "https://www.nasdaq.com/articles/xbi-hrtx-icpt-regn-large-inflows-detected-etf-2018-08-02", "https://www.nasdaq.com/articles/intercept-icpt-q2-loss-narrower-expected-2018-08-02", "https://www.nasdaq.com/articles/whats-in-store-for-intercept-icpt-this-earnings-season-2018-07-30", "https://www.nasdaq.com/articles/we-did-math-amca-can-go-30-2018-07-12", "https://www.nasdaq.com/articles/fridays-etf-movers-fbt-fm-2018-06-29", "https://www.nasdaq.com/articles/viking-therapeutics-buy-dip-2018-06-26", "https://www.nasdaq.com/articles/celgene-celg-q2-earnings%3A-disappointment-in-store-2018-07-23", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2018-06-18", "https://www.nasdaq.com/articles/nash-space-focus-galmed-glmd-posts-positive-data-2018-06-14", "https://www.nasdaq.com/articles/galmed-glmd-soars-on-positive-nash-data-on-aramchol-2018-06-13", "https://www.nasdaq.com/articles/interesting-icpt-put-and-call-options-june-2019-2018-06-12", "https://www.nasdaq.com/articles/intercept-icpt-up-3.8-since-earnings-report%3A-can-it-continue-2018-06-07", "https://www.nasdaq.com/articles/better-know-biotech-2-stocks-youve-got-know-about-2018-06-01", "https://www.nasdaq.com/articles/madrigals-nash-study-data-encouraging-stock-skyrockets-2018-06-01", "https://www.nasdaq.com/articles/most-undervalued-nash-drug-stock-and-wall-street-ignoring-it-2018-06-26", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2018-06-18", "https://www.nasdaq.com/articles/nash-space-focus-galmed-glmd-posts-positive-data-2018-06-14", "https://www.nasdaq.com/articles/notable-friday-option-activity-icpt-jnj-celg-2018-05-18", "https://www.nasdaq.com/articles/analysts-anticipate-14-upside-fxh-2018-05-10", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-shares-cross-above-200-dma-2018-05-09", "https://www.nasdaq.com/articles/intercept-icpt-q1-loss-narrower-than-expected-sales-lag-2018-05-08", "https://www.nasdaq.com/articles/why-viking-therapeutics-stock-fire-today-2018-05-31", "https://www.nasdaq.com/articles/whats-in-store-for-intercept-icpt-this-earnings-season-2018-04-30", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xbi-avxs-once-icpt-2018-04-18", "https://www.nasdaq.com/articles/gilead-gild-presents-encouraging-data-on-nash-therapies-2018-04-16", "https://www.nasdaq.com/articles/intercept-reports-phase-iii-sub-study-liver-biopsy-data-2018-04-16", "https://www.nasdaq.com/articles/bristol-myers-collaborates-with-harvard-fibrosis-network-2018-04-13", "https://www.nasdaq.com/articles/health-care-sector-update-04132018-cdnaplseipctingn-2018-04-13", "https://www.nasdaq.com/articles/health-care-sector-update-04132018-plseipctingn-2018-04-13", "https://www.nasdaq.com/articles/earnings-reaction-history-intercept-pharm-583-follow-through-indicator-49-sensitive-2018", "https://www.nasdaq.com/articles/math-shows-iyy-can-go-152-2018-04-09", "https://www.nasdaq.com/articles/4-top-stocks-investing-pharmas-next-35-billion-market-2018-04-08", "https://www.nasdaq.com/articles/3-high-growth-stocks-could-soar-2018-04-06", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-in-focus%3A-stock-moves-9.9-higher-2018-04-06", "https://www.nasdaq.com/articles/why-tesla-marathon-oil-and-intercept-pharmaceuticals-jumped-today-2018-04-05", "https://www.nasdaq.com/articles/health-care-sector-update-04052018-icptapricnat-2018-04-05", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-icpt-ulta-iff-2018-04-03", "https://www.nasdaq.com/articles/tuesday-410-insider-buying-report-icpt-kmx-2018-04-10", "https://www.nasdaq.com/articles/2-cheap-growth-stocks-buy-right-now-2018-03-08", "https://www.nasdaq.com/articles/analysts-forecast-12-upside-eqal-2018-03-08", "https://www.nasdaq.com/articles/intercept-icpt-q4-earnings-sales-lag-on-dull-ocaliva-2018-02-15", "https://www.nasdaq.com/articles/intercept-icpt-misses-q4-earnings-sales-2018-02-14", "https://www.nasdaq.com/articles/intercept-starts-oca-trial-for-nash-patients-with-cirrhosis-2018-02-13", "https://www.nasdaq.com/articles/will-ocaliva-sales-dampen-intercepts-icpt-q4-earnings-2018-02-12", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-xom-now-icpt-2018-02-01", "https://www.nasdaq.com/articles/intercept-icpt-up-6.7-since-earnings-report%3A-can-it-continue-2018-03-16", "https://www.nasdaq.com/articles/primary-reason-intercept-pharmaceuticals-inc-was-nearly-halved-2017-2018-01-12", "https://www.nasdaq.com/articles/intercept-icpt-stock-loses-sheen-in-2017%3A-what-lies-ahead-2017-12-29", "https://www.nasdaq.com/articles/biotech-stock-just-pushed-back-key-trial-until-early-2018-2017-12-28", "https://www.nasdaq.com/articles/7-life-science-stocks-to-buy-today-2017-11-14", "https://www.nasdaq.com/articles/notable-friday-option-activity-icpt-gild-clvs-2017-11-10", "https://www.nasdaq.com/articles/intercept-icpt-q3-loss-narrower-than-expected-sales-beat-2017-11-02", "https://www.nasdaq.com/articles/intercept-pops-after-topping-third-quarter-sales-earnings-views-2017-11-01", "https://www.nasdaq.com/articles/biotech-roundup-whos-popping-drug-merger-earnings-news-2018-02-01", "https://www.nasdaq.com/articles/earnings-reaction-history-intercept-pharm-500-follow-through-indicator-44-sensitive-2017", "https://www.nasdaq.com/articles/heres-why-its-oca-liftoff-intercept-pharmaceuticals-inc-2017-11-01", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-gpro-mar-icpt-2017-11-01", "https://www.nasdaq.com/articles/whats-in-the-offing-for-intercept-icpt-in-q3-earnings-2017-10-30", "https://www.nasdaq.com/articles/3-reasons-ive-been-aggressively-buying-intercept-pharmaceuticals-2017-10-30", "https://www.nasdaq.com/articles/bristol-myers-bmy-target-extend-partnership-for-nash-study-2017-10-13", "https://www.nasdaq.com/articles/heres-why-intercept-icpt-stock-lost-37-so-far-in-2017-2017-10-12", "https://www.nasdaq.com/articles/intercept-icpt-reports-narrower-q3-loss-2017-11-01", "https://www.nasdaq.com/articles/intercept-dives-along-ocaliva-prescriptions-fda-warning-2017-10-06", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-tronox-and-mobileiron-jumped-today-2017-10-05", "https://www.nasdaq.com/articles/why-these-biotechs-are-leading-group-near-21-month-high-2017-10-04", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc-was-halved-september-presents-intriguing-opportunity-2017-10", "https://www.nasdaq.com/articles/sum-parts-xbi-could-be-worth-106-2017-10-03", "https://www.nasdaq.com/articles/3-beaten-down-biotech-stocks-buy-right-now-2017-10-02", "https://www.nasdaq.com/articles/will-conatus-liver-disease-candidate-drive-long-term-growth-2017-09-28", "https://www.nasdaq.com/articles/bitcoin-vs-biotech-which-smarter-investment-2017-10-08", "https://www.nasdaq.com/articles/implied-volatility-surging-for-intercept-pharmaceuticals-icpt-stock-options-2017-09-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-reiterates-2017-outlook-intercept-hit-ocaliva-safety-issues", "https://www.nasdaq.com/articles/company-news-for-sep-25-2017-2017-09-25", "https://www.nasdaq.com/articles/pre-market-most-active-sep-25-2017-aapl-gsk-icpt-vsar-mt-tlt-rig-azn-qqq-mu-gm-chk-2017-09", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-sinking-again-today-2017-09-22", "https://www.nasdaq.com/articles/health-care-sector-update-09222017-icptjunovsar-2017-09-22", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-tumbling-today-2017-09-21", "https://www.nasdaq.com/articles/intercept-icpt-provides-safety-guidelines-for-ocaliva-2017-09-27", "https://www.nasdaq.com/articles/implied-volatility-surging-for-intercept-pharmaceuticals-icpt-stock-options-2017-09-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-reiterates-2017-outlook-intercept-hit-ocaliva-safety-issues", "https://www.nasdaq.com/articles/company-news-for-sep-25-2017-2017-09-25", "https://www.nasdaq.com/articles/notable-thursday-option-activity-nflx-avxs-icpt-2017-09-14", "https://www.nasdaq.com/articles/sell-intercept-pharmaceuticals-stock-overblown-2017-09-13", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc-icpt-stock-dives-on-drug-warning-2017-09-12", "https://www.nasdaq.com/articles/heres-why-intercept-pharmaceuticals-tumbling-today-2017-09-12", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-transocean-and-us-steel-slumped-today-2017-09-21", "https://www.nasdaq.com/articles/morning-movers-alcoa-gains-upgrade-teva-soars-sale-2017-09-12", "https://www.nasdaq.com/articles/pre-market-most-active-sep-12-2017-teva-aeg-sage-aapl-tvix-mt-nok-azn-cs-mrns-icpt-kweb", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-health-insurance-innovations-and-investors-real-estate-trust", "https://www.nasdaq.com/articles/5-most-hated-biotech-stocks-market-are-they-buys-2017-09-01", "https://www.nasdaq.com/articles/analysts-predict-12-gains-ahead-fbt-2017-08-31", "https://www.nasdaq.com/articles/why-is-intercept-pharmaceuticals-icpt-down-3.9-since-the-last-earnings-report-2017-08-31", "https://www.nasdaq.com/articles/icpt-crosses-above-key-moving-average-level-2017-08-30", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-becomes-oversold-icpt-2017-09-12", "https://www.nasdaq.com/articles/morning-movers-alcoa-gains-upgrade-teva-soars-sale-2017-09-12", "https://www.nasdaq.com/articles/pre-market-most-active-sep-12-2017-teva-aeg-sage-aapl-tvix-mt-nok-azn-cs-mrns-icpt-kweb", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-health-insurance-innovations-and-investors-real-estate-trust", "https://www.nasdaq.com/articles/5-most-hated-biotech-stocks-market-are-they-buys-2017-09-01", "https://www.nasdaq.com/articles/intercept-icpt-reports-narrower-q2-loss-2017-07-31", "https://www.nasdaq.com/articles/earnings-reaction-history-intercept-pharm-417-follow-through-indicator-47-sensitive-2017", "https://www.nasdaq.com/articles/will-conatus-key-candidate-emricasan-drive-long-term-growth-2017-08-21", "https://www.nasdaq.com/articles/heres-my-top-stock-buy-august-2017-08-14", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-becomes-oversold-icpt-2017-08-09", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-icpt-2017-08-01", "https://www.nasdaq.com/articles/intercept-icpt-posts-narrower-than-expected-loss-in-q2-2017-08-01", "https://www.nasdaq.com/articles/can-horizon-pharma-hznp-spring-a-surprise-in-q2-earnings-2017-07-31", "https://www.nasdaq.com/articles/can-intercept-icpt-beat-estimates-this-earnings-season-2017-07-25", "https://www.nasdaq.com/articles/can-prothena-prta-deliver-a-beat-this-earnings-season-2017-07-28", "https://www.nasdaq.com/articles/best-stock-new-york-intercept-pharmaceuticals-2017-07-21", "https://www.nasdaq.com/articles/what-to-expect-from-keryx-kerx-this-earnings-season-2017-07-21", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-alexion-alxn-this-earnings-season-2017-07-20", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-cenx-icpt-cacc-2017-07-07", "https://www.nasdaq.com/articles/commit-purchase-intercept-pharmaceuticals-95-earn-107-annualized-using-options-2017-07-06", "https://www.nasdaq.com/articles/3-mid-cap-biotech-stocks-may-be-red-hot-takeover-candidates-2017-07-05", "https://www.nasdaq.com/articles/will-radius-health-rdus-disappoint-this-earnings-season-2017-07-25", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-icpt-emn-c-2017-06-19", "https://www.nasdaq.com/articles/intercept-icpt-releases-data-from-phase-ii-flint-trial-2017-06-13", "https://www.nasdaq.com/articles/intercept-icpt-down-3.5-since-earnings-report%3A-can-it-rebound-2017-06-12", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-looks-good%3A-stock-adds-5.3-in-session-2017-06-05", "https://www.nasdaq.com/articles/3-stocks-vertex-pharmaceuticals-return-potential-2017-06-03", "https://www.nasdaq.com/articles/intercepts-icpt-liver-drug-ocaliva-approved-in-canada-2017-05-29", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-dvn-nee-icpt-2017-05-24", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-icpt-2017-07-03", "https://www.nasdaq.com/articles/intercept-icpt-q1-loss-narrower-than-expected-sales-beat-2017-05-05", "https://www.nasdaq.com/articles/intercept-icpt-reports-narrower-loss-q1-2017-05-04", "https://www.nasdaq.com/articles/earnings-reaction-history-intercept-pharm-364-follow-through-indicator-48-sensitive-2017", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-sm-anet-icpt-2017-05-04", "https://www.nasdaq.com/articles/radius-health-rdus-q1-earnings%3A-whats-in-store-2017-05-01", "https://www.nasdaq.com/articles/is-intercept-icpt-poised-for-a-beat-this-earnings-season-2017-04-28", "https://www.nasdaq.com/articles/gilead-gild-q1-earnings%3A-stock-likely-to-beat-estimates-2017-04-25", "https://www.nasdaq.com/articles/knocking-door-2400-2017-05-11", "https://www.nasdaq.com/articles/celgene-celg-to-post-q1-earnings%3A-whats-in-the-cards-2017-04-24", "https://www.nasdaq.com/articles/should-gilead-sciences-be-worried-about-allergan-2017-04-23", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q1-earnings%3A-will-it-beat-again-2017-04-21", "https://www.nasdaq.com/articles/alexion-alxn-q1-earnings%3A-can-the-stock-pull-a-surprise-2017-04-21", "https://www.nasdaq.com/articles/novartis-nvs-q1-earnings%3A-will-the-stock-disappoint-2017-04-20", "https://www.nasdaq.com/articles/allergan-agn-collaborates-with-novartis-to-treat-nash-2017-04-19", "https://www.nasdaq.com/articles/commit-buy-intercept-pharmaceuticals-80-earn-9-annualized-using-options-2017-04-06", "https://www.nasdaq.com/articles/bristol-myers-bmy-to-post-q1-earnings%3A-whats-in-store-2017-04-25", "https://www.nasdaq.com/articles/intercept-icpt-q4-loss-wider-than-expected-revenues-beat-2017-02-24", "https://www.nasdaq.com/articles/intercept-icpt-reports-wider-q4-loss-2017-02-23", "https://www.nasdaq.com/articles/health-care-sector-update-02232017-icpt-2017-02-23", "https://www.nasdaq.com/articles/earnings-reaction-history-intercept-pharm-400-follow-through-indicator-47-sensitive-2017", "https://www.nasdaq.com/articles/intercept-icpt-to-post-q4-earnings%3A-whats-in-the-cards-2017-02-21", "https://www.nasdaq.com/articles/investors-are-betting-big-against-intercept-pharmaceuticals-are-they-wrong-2017-02-17", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-latest-news-caused-stock-jump-2017-02-11", "https://www.nasdaq.com/articles/relative-strength-alert-intercept-pharmaceuticals-2017-04-05", "https://www.nasdaq.com/articles/math-shows-iyh-can-go-170-2017-02-07", "https://www.nasdaq.com/articles/3-biotechs-likely-be-acquired-2017-2017-01-22", "https://www.nasdaq.com/articles/alcobra-stock-down-on-poor-late-stage-data-on-adhd-drug-2017-01-18", "https://www.nasdaq.com/articles/merrimack-mack-goes-uphill%3A-is-a-turnaround-likely-2017-01-17", "https://www.nasdaq.com/articles/should-investors-bet-gilead-sciences-version-30-2017-01-14", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-psx-cmg-icpt-2017-01-11", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-web-icpt-fcx-2017-02-10", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-jumps%3A-stock-rises-9.3-2016-12-29", "https://www.nasdaq.com/articles/commit-buy-intercept-pharmaceuticals-70-earn-74-using-options-2016-12-28", "https://www.nasdaq.com/articles/why-sandstorm-gold-weis-markets-and-intercept-pharmaceuticals-jumped-today-2016-12-28", "https://www.nasdaq.com/articles/could-these-2-small-biotechs-beat-allergan-and-gilead-sciences-2016-12-17", "https://www.nasdaq.com/articles/5-stocks-could-make-you-rich-2016-12-16", "https://www.nasdaq.com/articles/intercept-icpt-ocaliva-gains-conditional-approval-in-eu-2016-12-15", "https://www.nasdaq.com/articles/math-shows-jkh-can-go-180-2016-12-01", "https://www.nasdaq.com/articles/3-companies-whose-sales-could-double-2017-2017-01-07", "https://www.nasdaq.com/articles/intercept-icpt-q3-loss-narrower-than-expected-sales-miss-2016-11-04", "https://www.nasdaq.com/articles/intercept-icpt-reports-narrower-than-expected-q3-loss-2016-11-03", "https://www.nasdaq.com/articles/earnings-reaction-history-intercept-pharm-444-follow-through-indicator-52-sensitive-2016", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-angi-icpt-dbd-2016-11-02", "https://www.nasdaq.com/articles/drug-stocks-q3-earnings-roster-for-nov-3-icpt-exel-akrx-2016-11-02", "https://www.nasdaq.com/articles/intercept-icpt-q3-earnings-preview%3A-whats-in-the-cards-2016-11-01", "https://www.nasdaq.com/articles/40-billion-opportunity-3-biotechs-poised-dominate-2016-10-31", "https://www.nasdaq.com/articles/charles-payne-on-biotech%3A-biogen-inc-biib-intercept-pharmaceuticals-inc-icpt-2016-11-29", "https://www.nasdaq.com/articles/intercept-icpt-ocaliva-wins-positive-chmp-opinion-for-pbc-2016-10-17", "https://www.nasdaq.com/articles/notable-monday-option-activity-icpt-pg-seas-2016-10-03", "https://www.nasdaq.com/articles/analysts-forecast-10-upside-jkh-2016-09-30", "https://www.nasdaq.com/articles/nonalcoholic-steatohepatitis-whats-market-opportunity-and-who-are-major-players-2016-09-29", "https://www.nasdaq.com/articles/nonalcoholic-steatohepatitis-nash-whats-market-opportunity-and-who-are-major-players-2016", "https://www.nasdaq.com/articles/biotech-etfs-focus-tobira-therapeutics-massive-gain-2016-09-21", "https://www.nasdaq.com/articles/allergan-buys-nash-therapy-maker-tobira-at-huge-premium-2016-09-21", "https://www.nasdaq.com/articles/vertex-vrtx-q3-earnings%3A-whats-in-store-for-the-stock-2016-10-20", "https://www.nasdaq.com/articles/we-did-math-bbh-can-go-136-2016-08-26", "https://www.nasdaq.com/articles/intercept-icpt-ocaliva-phase-iii-poise-data-published-2016-08-18", "https://www.nasdaq.com/articles/health-care-sector-update-08182016-arwricptceru-2016-08-18", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-rubi-icpt-bwld-2016-08-15", "https://www.nasdaq.com/articles/intercept-icpt-reports-narrower-than-expected-q2-loss-2016-08-08", "https://www.nasdaq.com/articles/intercept-icpt-posts-narrower-expected-loss-q2-2016-08-04", "https://www.nasdaq.com/articles/allergan-plc-ordinary-shares%3A-what-is-agn-getting-for-its-billion-dollars-2016-09-20", "https://www.nasdaq.com/articles/looking-beyond-hepatitis-c-heres-how-gilead-could-make-another-10-billion-annually-2016-08", "https://www.nasdaq.com/articles/we-did-math-bbh-can-go-136-2016-08-26", "https://www.nasdaq.com/articles/intercept-icpt-ocaliva-phase-iii-poise-data-published-2016-08-18", "https://www.nasdaq.com/articles/health-care-sector-update-08182016-arwricptceru-2016-08-18", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-rubi-icpt-bwld-2016-08-15", "https://www.nasdaq.com/articles/intercept-icpt-reports-narrower-than-expected-q2-loss-2016-08-08", "https://www.nasdaq.com/articles/pfizer-pfe-likely-to-beat-earnings-in-q2-again-2016-07-29", "https://www.nasdaq.com/articles/earnings-reaction-history-intercept-pharm-375-follow-through-indicator-51-sensitive-2016", "https://www.nasdaq.com/articles/merck-mrk-q2-earnings-will-stock-pull-surprise-2016-07-26", "https://www.nasdaq.com/articles/vertex-vrtx-report-q2-earnings-surprise-store-2016-07-25", "https://www.nasdaq.com/articles/amgen-amgn-may-beat-q2-earnings-will-stock-gain-2016-07-25", "https://www.nasdaq.com/articles/4-rock-solid-cheap-biotech-stocks-2016-07-16", "https://www.nasdaq.com/articles/3-stocks-could-make-you-rich-2016-07-09", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xbi-ions-alks-icpt-2016-07-01", "https://www.nasdaq.com/articles/why-pier-1-imports-intercept-pharmaceuticals-and-costamare-slumped-today-2016-06-30", "https://www.nasdaq.com/articles/abbvie-abbv-q2-earnings-will-stock-pull-surprise-2016-07-26", "https://www.nasdaq.com/articles/notable-thursday-option-activity-jnj-ncmi-icpt-2016-06-30", "https://www.nasdaq.com/articles/health-care-sector-update-06302016-syrstthiopkicpt-2016-06-30", "https://www.nasdaq.com/articles/analysts-anticipate-she-will-reach-69-2016-06-13", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-sarepta-biogen-abbvie-intercept-and-ionis-2016-06-02", "https://www.nasdaq.com/articles/icpt-makes-bullish-cross-above-critical-moving-average-2016-06-01", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-ckec-icpt-gm-2016-06-01", "https://www.nasdaq.com/articles/intercepts-icpt-liver-dug-ocaliva-approved-by-the-fda-2016-05-30", "https://www.nasdaq.com/articles/health-care-sector-update-06302016-akertthiicpt-2016-06-30", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-lgf-wsm-icpt-2016-05-13", "https://www.nasdaq.com/articles/math-shows-eqwm-can-go-43-2016-05-12", "https://www.nasdaq.com/articles/intercept-icpt-q1-loss-narrower-than-expected-sales-lag-2016-05-06", "https://www.nasdaq.com/articles/earnings-reaction-history-intercept-pharm-286-follow-through-indicator-55-sensitive-2016", "https://www.nasdaq.com/articles/intercept-icpt%3A-stock-likely-to-disappoint-in-q1-earnings-2016-05-03", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xbi-mdvn-nbix-icpt-2016-04-21", "https://www.nasdaq.com/articles/synta-stock-up-on-merger-deal-with-madrigal-pharmaceuticals-2016-04-15", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-icpt-dy-z-2016-05-24", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-intercept-clovis-abbvie-relypsa-and-horizon-pharma-2016", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-experiences-big-inflow-2016-04-13", "https://www.nasdaq.com/articles/how-parts-add-she-headed-68-2016-04-11", "https://www.nasdaq.com/articles/last-weeks-best-healthcare-etf-2016-04-08", "https://www.nasdaq.com/articles/intercepts-icpt-ocaliva-gets-favorable-fda-panel-vote-2016-04-08", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-regeneron-medivation-and-intercept-2016-04-07", "https://www.nasdaq.com/articles/intercept-icpt-up-ahead-of-advisory-committee-meeting-2016-04-06", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-reports-phase-iii-data-on-ocaliva-2016-04-15", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-experiences-big-outflow-2016-04-05", "https://www.nasdaq.com/articles/health-care-sector-update-04052016-icpt-anip-2016-04-05", "https://www.nasdaq.com/articles/why-lumber-liquidators-solarcity-and-intercept-pharmaceuticals-jumped-today-2016-04-05", "https://www.nasdaq.com/articles/gilead-descovy-wins-fda-nod-to-buy-nimbus-liver-program-2016-04-05", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-rgr-lad-icpt-2016-04-04", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-xbi-the-best-biotech-investment-now-2016-03-24", "https://www.nasdaq.com/articles/intercept-icpt-q4-loss-wider-y-y-focus-on-liver-drug-2016-02-24", "https://www.nasdaq.com/articles/tuesdays-etf-movers-fbt-dwx-2016-04-05", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-experiences-big-outflow-2016-04-05", "https://www.nasdaq.com/articles/health-care-sector-update-04052016-icpt-anip-2016-04-05", "https://www.nasdaq.com/articles/why-lumber-liquidators-solarcity-and-intercept-pharmaceuticals-jumped-today-2016-04-05", "https://www.nasdaq.com/articles/gilead-descovy-wins-fda-nod-to-buy-nimbus-liver-program-2016-04-05", "https://www.nasdaq.com/articles/last-weeks-best-healthcare-etf-2016-02-13", "https://www.nasdaq.com/articles/health-care-sector-update-02122016-icptxbioopktrxc-2016-02-12", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-inc-skyrocketing-today-2016-02-12", "https://www.nasdaq.com/articles/intercept-icpt-posts-wider-expected-loss-q4-2016-02-23", "https://www.nasdaq.com/articles/whats-in-store-for-intercept-icpt-this-earnings-season-2016-02-19", "https://www.nasdaq.com/articles/how-pieces-add-iwf-targets-113-2016-02-03", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-now-oversold-icpt-2016-02-02", "https://www.nasdaq.com/articles/first-week-september-16th-options-trading-intercept-pharmaceuticals-icpt-2016-01-22", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-enters-oversold-territory-icpt-2016-01-11", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-sold-december-and-heres-why-2016-01-07", "https://www.nasdaq.com/articles/intercept-icpt-down-on-delay-in-fdas-verdict-on-lead-drug-2015-12-18", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-dish-cpn-icpt-2016-02-12", "https://www.nasdaq.com/articles/1-company-gilead-sciences-should-consider-buying-right-now-2016-02-06", "https://www.nasdaq.com/articles/how-pieces-add-iwf-targets-113-2016-02-03", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-now-oversold-icpt-2016-02-02", "https://www.nasdaq.com/articles/commit-buy-intercept-pharmaceuticals-95-earn-79-using-options-2015-11-12", "https://www.nasdaq.com/articles/intercept-icpt-posts-narrower-than-expected-loss-in-q3-2015-11-10", "https://www.nasdaq.com/articles/epizymes-q3-loss-wider-than-expected-pipeline-in-focus-2015-11-10", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-sune-rmti-icpt-2015-11-10", "https://www.nasdaq.com/articles/health-care-sector-update-12152015-icpt-ktov-neot-gsk-2015-12-15", "https://www.nasdaq.com/articles/2015s-worst-clinical-failures-2015-12-12", "https://www.nasdaq.com/articles/pre-market-earnings-report-november-9-2015-pcln-dish-amg-alny-wwav-isis-comm-sni-icpt-hpt", "https://www.nasdaq.com/articles/will-puma-biotechnology-pbyi-surprise-in-q3-earnings-2015-11-06", "https://www.nasdaq.com/articles/will-merrimack-mack-surprise-estimates-in-q3-earnings-2015-11-06", "https://www.nasdaq.com/articles/will-intercept-icpt-beat-estimates-in-q3-earnings-2015-11-06", "https://www.nasdaq.com/articles/can-inogen-ingn-pull-a-surprise-this-earnings-season-2015-11-06", "https://www.nasdaq.com/articles/catalyst-pharmaceutical-cprx%3A-a-peek-into-q3-earnings-2015-11-06", "https://www.nasdaq.com/articles/intercept-icpt-posts-narrower-than-expected-loss-in-q3-2015-11-09", "https://www.nasdaq.com/articles/whats-in-store-for-trovagene-trov-ahead-of-q3-earnings-2015-11-06", "https://www.nasdaq.com/articles/pre-market-earnings-report-november-9-2015-pcln-dish-amg-alny-wwav-isis-comm-sni-icpt-hpt", "https://www.nasdaq.com/articles/will-puma-biotechnology-pbyi-surprise-in-q3-earnings-2015-11-06", "https://www.nasdaq.com/articles/will-merrimack-mack-surprise-estimates-in-q3-earnings-2015-11-06", "https://www.nasdaq.com/articles/will-intercept-icpt-beat-estimates-in-q3-earnings-2015-11-06", "https://www.nasdaq.com/articles/can-inogen-ingn-pull-a-surprise-this-earnings-season-2015-11-06", "https://www.nasdaq.com/articles/catalyst-pharmaceutical-cprx%3A-a-peek-into-q3-earnings-2015-11-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-celgene-juno-therapeutics-intercept-biomarin-and", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-files-for-oca-in-u.s.-and-europe-analyst-blog-2015-06-30", "https://www.nasdaq.com/articles/following-hepatitis-c-could-be-next-disease-researchers-cure-2015-05-21", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-in-focus%3A-stock-tanks-16.1-tale-of-the-tape-2015-05-20", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-reveals-phase-iii-oca-study-plan-analyst-blog-2015-05-20", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-shares-are-tumbling-2015-05-19", "https://www.nasdaq.com/articles/health-care-sector-update-05192015-icpt-hway-adxs-2015-05-19", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt%3A-q2-earnings-preview-analyst-blog-2015-08-04", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-celgene-juno-therapeutics-intercept-biomarin-and", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-files-for-oca-in-u.s.-and-europe-analyst-blog-2015-06-30", "https://www.nasdaq.com/articles/following-hepatitis-c-could-be-next-disease-researchers-cure-2015-05-21", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-in-focus%3A-stock-tanks-16.1-tale-of-the-tape-2015-05-20", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-reveals-phase-iii-oca-study-plan-analyst-blog-2015-05-20", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-shares-are-tumbling-2015-05-19", "https://www.nasdaq.com/articles/health-care-sector-update-05192015-icpt-hway-adxs-2015-05-19", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt%3A-q2-earnings-preview-analyst-blog-2015-08-04", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-releases-data-on-lead-drug-analyst-blog-2015-04-24", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-fbt-icpt-pcyc-cldx-2015-04-22", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-moves-market-cap-rank-passing-first-solar-2015-04-20", "https://www.nasdaq.com/articles/use-options-chance-buy-icpt-53-discount-2015-03-10", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-loss-narrows-in-q4-tale-of-the-tape-2015-03-02", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-will-it-miss-q4-earnings-analyst-blog-2015-02-28", "https://www.nasdaq.com/articles/fbt-icpt-nvax-pcyc-etf-inflow-alert-2015-02-27", "https://www.nasdaq.com/articles/health-care-sector-update-03172015-cldx-bmrn-icpt-2015-03-17", "https://www.nasdaq.com/articles/mondays-etf-movers-bbh-xop-2015-03-16", "https://www.nasdaq.com/articles/could-clinical-stage-biotech-stock-soar-april-2015-03-12", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-march-2015-03-11", "https://www.nasdaq.com/articles/use-options-chance-buy-icpt-53-discount-2015-03-10", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-loss-narrows-in-q4-tale-of-the-tape-2015-03-02", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-will-it-miss-q4-earnings-analyst-blog-2015-02-28", "https://www.nasdaq.com/articles/fbt-icpt-nvax-pcyc-etf-inflow-alert-2015-02-27", "https://www.nasdaq.com/articles/health-care-sector-update-03172015-cldx-bmrn-icpt-2015-03-17", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc-breaks-above-200-day-moving-average-bullish-icpt-2015-02-23", "https://www.nasdaq.com/articles/does-small-biotech-have-making-blockbuster-2015-02-07", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-jumps%3A-stock-adds-9.5-tale-of-the-tape-2015-02-06", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-inc-shares-shot-higher-29-january-2015-02-05", "https://www.nasdaq.com/articles/mondays-etf-movers-xop-xbi-2015-02-02", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-shares-soared-today-2015-01-30", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-oca-now-breakthrough-therapy-analyst-blog-2015-01-30", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-2-2015-endp-icpt-ssys-bid-pegi-ptla-stng-core-vnr-xlrn", "https://www.nasdaq.com/articles/commit-buy-intercept-pharmaceuticals-100-earn-133-using-options-2015-01-26", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-ryt-2015-01-26", "https://www.nasdaq.com/articles/tuesdays-etf-movers-fbt-gdx-2015-01-13", "https://www.nasdaq.com/articles/why-intercept-pharma-icpt-stock-might-be-a-great-pick-tale-of-the-tape-2015-01-12", "https://www.nasdaq.com/articles/did-gilead-sciences-just-buy-its-next-blockbuster-drug-2015-01-10", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-crumbles%3A-icpt-falls-9.6-in-session-tale-of-the-tape-2015", "https://www.nasdaq.com/articles/3-biotech-stocks-were-watching-closest-ahead-jpmorgan-healthcare-conference-2015-01-05", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-xop-2015-01-05", "https://www.nasdaq.com/articles/etf-holds-stocks-insiders-want-own-2015-01-02", "https://www.nasdaq.com/articles/health-care-sector-update-12182014-icpt-mrk-cpxx-2014-12-18", "https://www.nasdaq.com/articles/why-intercept-pharmaceuticals-inc-stock-was-throttled-november-2014-12-01", "https://www.nasdaq.com/articles/will-intercept-pharmaceuticals-icpt-q3-loss-narrow-analyst-blog-2014-11-06", "https://www.nasdaq.com/articles/pre-market-earnings-report-november-7-2014-bam-hum-bpl-icpt-isis-stay-agio-erf-lxp-ctb-sji", "https://www.nasdaq.com/articles/5-best-biotech-stocks-2014so-far-2014-09-26", "https://www.nasdaq.com/articles/sector-update-health-stocks-generally-higher-pre-bell-2014-11-07", "https://www.nasdaq.com/articles/sector-update-health-care-2014-11-07", "https://www.nasdaq.com/articles/stocks-pull-ahead-close-ending-higher-third-consecutive-week-2014-11-07", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-posts-earnings-pipeline-in-focus-analyst-blog-2014-08-13", "https://www.nasdaq.com/articles/pre-market-most-active-aug-12-2014-twtr-xiv-icpt-bmlj-qqq-aapl-sol-tvix-mnkd-kate-gsk-bpl", "https://www.nasdaq.com/articles/sector-update-health-care-2014-08-12-0", "https://www.nasdaq.com/articles/sector-update-health-care-shares-steady-early-trade-2014-08-12", "https://www.nasdaq.com/articles/3-hot-ways-play-biotechnology-bonanza-2014-09-17", "https://www.nasdaq.com/articles/intercept-pharma-icpt-shares-soar-liver-disease-drug-news-stocks-news-2014-08-12", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc-finally-releases-flint-trial-data-2014-08-11", "https://www.nasdaq.com/articles/after-hours-earnings-report-august-11-2014-vtr-nuan-icpt-rax-opk-mr-mtz-trak-cvg-czr-htht", "https://www.nasdaq.com/articles/why-i-love-nasdaq-exchanges-top-10-performers-year-date-2014-06-19", "https://www.nasdaq.com/articles/intercepts-obeticholic-acid-gets-fast-track-status-analyst-blog-2014-05-29", "https://www.nasdaq.com/articles/intercept-sinks-on-cholesterol-issue-analyst-blog-2014-05-21", "https://www.nasdaq.com/articles/wednesdays-etf-movers-gdx-xbi-2014-04-23", "https://www.nasdaq.com/articles/stock-market-today%3A-russian-sanctions-and-oil-in-focus-8-12-14-stocks-in-the-news-2014-08", "https://www.nasdaq.com/articles/sector-update-healthcares-flat-lower-pre-market-lexicon-soars-20-study-diabetes-treatment", "https://www.nasdaq.com/articles/sector-update-healthcares-2014-04-14", "https://www.nasdaq.com/articles/positive-results-on-intercept-pharmas-oca-analyst-blog-2014-04-14", "https://www.nasdaq.com/articles/intercept-pharma-prices-1m-share-offering-shares-down-analyst-blog-2014-04-08", "https://www.nasdaq.com/articles/3-etfs-tumble-most-biotech-sell-etf-news-and-commentary-2014-03-24", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-experiences-big-inflow-2014-03-21", "https://www.nasdaq.com/articles/intercept-sees-weakness-in-earnings-result-analyst-blog-2014-03-18", "https://www.nasdaq.com/articles/tuesdays-etf-movers-xbi-ilf-2014-04-22", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-03-17", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-14-2014-icpt-inn-2014-03-14", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xbi-icpt-itmn-aria-2014-03-13", "https://www.nasdaq.com/articles/biotech-etfs-flash-buy-signals-xbi-ibb-bbh-icpt-2014-03-13", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xbi-icpt-itmn-aria-2014-03-05", "https://www.nasdaq.com/articles/precious-metals-health-care-led-mutual-funds-feb-2014-03-04", "https://www.nasdaq.com/articles/which-sector-produced-8-10-top-percentage-gainers-2014-2014-02-12", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-higher-pre-market-inovio-dips-q4-results-2014-03-17", "https://www.nasdaq.com/articles/2-etfs-riding-high-on-q4-earnings-results-etf-news-and-commentary-2014-02-05", "https://www.nasdaq.com/articles/3-sector-etfs-surging-to-start-2014-etf-news-and-commentary-2014-01-20", "https://www.nasdaq.com/articles/pre-market-most-active-jan-13-2014-siri-beam-lulu-twtr-alu-bac-wen-msf-icpt-fb-vod-expr", "https://www.nasdaq.com/articles/us-ipo-recap-twenty-companies-file-or-set-terms-ipos-2014-01-13", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-higher-pre-market-intercept-pharma-30-adding-thursdays-big", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-10-1", "https://www.nasdaq.com/articles/intercept-pharma-icpt-pushes-spdr-biotech-etf-ahead-rivals-etf-news-and-commentary-2014-01", "https://www.nasdaq.com/articles/the-guide-to-surging-biotech-etfs-etf-news-and-commentary-2014-02-11", "https://www.nasdaq.com/articles/healthcare-stocks-adding-earlier-gains-intercept-pharmaceuticals-extends-rally-another-day", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-10", "https://www.nasdaq.com/articles/pre-market-most-active-jan-9-2014-alu-jcp-nok-av-bac-ck-icpt-sqnm-fb-qqq-achn-bbby-2014-01", "https://www.nasdaq.com/articles/healthcare-stocks-adding-earlier-gains-big-rally-intercept-pharma-also-raising-peers-2014", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-09", "https://www.nasdaq.com/articles/intercept-to-provide-update-on-pipeline-analyst-blog-2014-01-06", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-inc.-icpt-enters-overbought-territory-tale-of-the-tape-2013-12", "https://www.nasdaq.com/articles/no-jobs-no-problem-2014-01-10", "https://www.nasdaq.com/articles/weeky-cfo-sells-highlight-adbe-hae-wage-ovti-icpt-2013-06-24", "https://www.nasdaq.com/articles/pll-expands-into-research-analyst-blog-2013-03-06", "https://www.nasdaq.com/articles/shutterstock-prices-ipo-17-above-range-2012-10-10", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-increases-deal-size-prices-ipo-15-high-end-range-2012-10-10", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-sets-ipo-terms-2012-09-27", "https://www.nasdaq.com/articles/insiders-sell-shares-dolby-labs-and-intercept-pharma-qts-realty-trust-sees-purchase-2013"], "Content": []}